TWI237663B - Method of analyzing expression of gene - Google Patents

Method of analyzing expression of gene Download PDF

Info

Publication number
TWI237663B
TWI237663B TW090130806A TW90130806A TWI237663B TW I237663 B TWI237663 B TW I237663B TW 090130806 A TW090130806 A TW 090130806A TW 90130806 A TW90130806 A TW 90130806A TW I237663 B TWI237663 B TW I237663B
Authority
TW
Taiwan
Prior art keywords
sequence
restriction enzyme
gene expression
fragment
terminal
Prior art date
Application number
TW090130806A
Other languages
Chinese (zh)
Inventor
Masumi Abe
Toshiyuki Saito
Atsushi Hattori
Shinji Sato
Yasuji Kasama
Original Assignee
Masumi Abe
Maze Inc
Messengerscape Co Ltd
Nat Inst Radiolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Masumi Abe, Maze Inc, Messengerscape Co Ltd, Nat Inst Radiolog filed Critical Masumi Abe
Application granted granted Critical
Publication of TWI237663B publication Critical patent/TWI237663B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6851Quantitative amplification

Abstract

A cDNA is prepared from mRNA. The prepared cDNA is subjected to incision with two different types of restriction enzymes. The sequence of a portion of each of the fragments obtained as a result of treatment is determined, and the fragments are classified on the basis of the determined sequence by using a primer set. At the same time, the fragments are amplified in a manner that the relative expression magnitude thereof continues to be reflected therein. When the fragments have been classified into a predetermined number of fractions, the respective fractions are subjected to electrophoresis, and a gene expression profile is produced from the results.

Description

1237663 A7 B7 五、發明説明(1 ) (請先閱讀背面之注意事項再填寫本頁) 本申請案爲根據平成1 2年1 2月1 2日所申請之日 本專利申請編號2 0 〇 〇 — 3 7 7 8 8 7號,且根據該申 請案主張優先權。該申請案爲以引用編入本說明書中。 (技術領域) 本發明爲關於製作基因表現解析圖之方法,及解析基 因表現頻率之方法。 〔背景技術〕 西元2 0 0 0年,人類基因組的全部序列乃持續被定 出。由此所得之龐大的資料爲總括性理解於全部基因及特 定細胞中所表現包含此些基因產物之網路的基礎。 現在,於解明此類網絡之手段上所使用的方法爲如下 。例如,US5262311 及 US5599672 所揭 不之分類性顯示法(Differential Display ),特表平 經濟部智慧財產局員工消費合作社印製 1 0 - 5 1 1 0 0 2所揭示之基因表現的逐次分析法(即 , serial analysis of gene expression,以下簡稱爲 SAGE),及 USP 5807522, USP 5700637及USP 5744305所揭 示之微排列及D ΝΑ片斷等。 分類性顯示法爲使用細胞所調製之c D Ν Α做爲受質 的方法。對於該c D N A,經由使用複數種類之錨式引子 和任意之引子進行P C R,則可解析細胞中各種任意的基 因表現。但是,此方法不過僅爲分析全部基因中之一部分 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -4- 1237663 A7 B7 五、發明説明(2 ) 。又,因爲使用錨式引子和任意的引子,故具有缺乏再現 性之問題。 (請先閲讀背面之注意事項再填寫本頁) 相對地,對於細胞中之全表現基因可取得表現解析圖 之方法爲S A G E。S A G E爲使用由細胞所調製之 m R N A調製之c D N A進行解析。對於所調整之 c DNA進行限制酶處理,切出9至1 1個鹼基對左右之 片斷,並將來自各種c D N A之片斷予以連接後,進行定 序列。但是,SAGE中,爲了取得全表現基因之50% 左右種類之資料,必須進行約1 0萬回的定序列,使得費 用爲非常高。又,來自cDNA之片斷爲短,且實際上, 亦多不可能由片斷卓離出基因。 U S 5 8 0 7 5 2 2的微排列,及 USP 5700637 及 USP 5744305 的 D N A片斷爲於固相中將已知基因的探針予以固定。經由 該探針對樣品進行雜交作用,則可取得基因之表現解析圖 之方法。此些方法中,做爲檢測對象之基因其序列必須爲 已知不可。 經濟部智慧財產局員工消費合作社印製 〔發明之揭示〕 本發明之第一目的爲在於提供可於廣泛範圍中製作基 因之表現解析圖之方法。又,本發明之第二目的爲在於提 供關於對廣範圍基因解析其表現頻率之方法。 上述之第一目的爲藉由製作基因表現解析圖之方法, 其爲具備 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -5- 1237663 A7 B7 五、發明説明(3 ) (a )對於由細胞所萃取之m R N A ’合成其3 ’終 端加成標的物質之c D N A之工程, (b )將所得之反應產物以第一限制酶X予以切斷之 工程, (c )將具有對第一限制酶X之限制酶切斷部位之序 列呈互補性序列的X適應子,對於工程b所得之片斷進行 結合之工程, (d )經由對該標的物質結合具有高親和性之物質’ 則可回收工程c所得片斷之工程, (e )將工程d所回收之片斷以第二限制酶Y予以切 斷,除去結合至該標的物質之片斷,則可取得含有經切斷 c D N A 5 5側片斷之工程, (f )對於工程e所得之片斷,將具有對第二限制酶 Y辨識切斷部位之序列呈互補性序列之Y適應子予以加成 之工程, (g )使用對該X適應子序列具有互補性序列且其 3 ’終端具有任意二個鹼基序列N N之引子,與對該Y適 應子序列具有互補性序列且其3 ’終端具有任意二個鹼基 序列N N之引子,並對於前述工程f所得之片斷進行 PCR反應之工程, (h )將所得之P C R產物進行電泳,經由檢測移動 距離和波峰,製作基因表現解析圖之工程 之方法則可達成。 上述第二目的爲經由解析基因表現頻率之方法,其爲 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公釐) (請先閱讀背面之注意事項再填寫本頁) 訂 經濟部智慧財產局員工消費合作社印製 • 6 - 1237663 A7 B7 五、發明説明(4 ) 具備 (請先閱讀背面之注意事項再填寫本頁) (a )對於對照細胞和被檢細胞兩者,使用上述製作 基因表現解析圖之方法,製作基因表現解析圖之工程, (b )經由比較所得之二個基因表現解析圖,解析被 檢細胞之基因表現頻率變化之工程 之方法則可達成。 本發明之再其他目的及優點爲於下記記載及實施例中 說明。根據此些記載及實施例則可更加明白理解本案發明 。又,本發明之目的及優點爲經由下列所示之方法及組合 手段而可詳細細解,並且達成。 (圖面之簡單說明) 本說明書中所編入,成爲其一部分之附圖,必然爲詳 細說明本發明之較佳態樣,及,上述一般的記載及後述之 較佳態樣。又,爲用於使用說明本發明之基本的思想。 圖1爲示出根據本發明態樣之基因表現解析圖之製作 方法的槪要圖。 經濟部智慧財產局員工消費合作社印製 圖2爲示出根據本發明態樣之基因表現解析圖之製作 方法的流程。 圖3爲示出根據本發明態樣所得之基因表現解析圖之 一部分的圖示例。 圖4爲示出任意二個鹼基序列之組合圖。 圖5爲示出根據本發明態樣之基因表現解析圖所檢測 之基因比例圖。 本紙張尺度適用中國國家標準(CNS ) A4規格(21.0X297公釐) 1237663 A7 B7 五、發明説明(5 ) 圖6爲示出X適應子與Y適應子之較佳例之圖。 (請先閱讀背面之注意事項再填寫本頁) 圖7爲示出由數據庫所得之人類芳基胺N -乙醯轉移 酶之一部分基因序列圖。 圖8爲示出關於限制酶所得片斷之資料例圖。 圖9爲示出P 2 1表現之基因表現解析圖之一例之一 部分圖。 圖1 0爲示出m d m 2表現之基因表現解析圖之一例 之一部分圖。 圖1 1爲示出 cyclic G表現之基因表現解析圖之一 例之一部分圖。 圖1 2爲示出實施例2所使用之m R N A調製物組成 圖。 圖1 3爲示出實施例2中所得之基因表現解析圖之一 部分圖。 圖1 4爲示出實施例2中所得之基因表現解析圖之一 部分圖。 經濟部智慧財產局員工消費合作社印製 〔用以實施發明之最佳型態〕 1 ·發明之槪要 本發明者等人發現經由將特定細胞中所表現之基因如 何分類,則可大爲改變基因表現解析圖製作中操作之煩雜 性和費用效能。根據此發現爲基礎進行致力硏究,結果達 成本發明。 若根據本發明之一個態樣,則爲提供可一次且簡便製 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) -8 - 1237663 A7 B7 五、發明説明(6) (請先閱讀背面之注意事項再填寫本頁) 作包含於特定細胞中所表現之大約全部基因般之廣泛範圍 之基因的表現解析圖之方法。經由可辨識所表現之大約全 部的基因,則可比先前方法更加辨識更多之表現基因。 本發明之一態樣爲以限制酶D N A片斷長和聚合酶鏈 反應(即,P C R )爲基礎所開發之基因表現解析圖法。 經由此類基因表現解析圖方法’則可辨識所表現之幾乎全 部的基因,即,公知之基因和未知之基因均同樣可辨識。 又,此方法爲不會漏掉一個一個基因’且可分別辨識檢測 。此外,亦可決定其表現頻率。 經濟部智慧財產局員工消費合作社印製 製作本發明基因表現解析圖方法的基本特徵之一,爲 將特定細胞中表現之基因如下列般進行分類。於特定細胞 中表現之mRNA考慮爲約2 0 0 0 0種。首先,由表現 之mRNA合成出c DNA。將所得之雙股c DNA以適 切的二個限制酶予以切斷,製作各種具有僅可辨識長度之 片斷。其後,分類成可辨識所得片斷之一部分序列的 2 5 6個餾分。此分類爲首先使用任意設計的2 5 6種引 子組進行。於依舊反映相對的表現量下,於各引子組成數 個引子組中將該片斷放大,並且分類該片斷。對於分類, 所得之餾分,例如,各個2 5 6個餾分,以每1餾分進行 電泳,分離其成分。如此處理,由1個細胞所得之表現基 因資料爲被分類至可解析之程度爲止。如此,則可簡便製 作令幾乎全部之基因不令漏掉,且可正確捕捉一個一個基 因表現量之基因表現解析圖。 例如,使用圖1說明分類成2 5 6個餾分的具體性手 本紙張尺度適用中.國國家標準(CNS ) A4規格(21〇Χ 297公釐) -9- 1237663 A7 ___B7 五、發明説明(7) (請先閱讀背面之注意事項再填寫本頁) 經濟部智慧財產局員工消費合作社印製 段。由所表現之m R N A群1合成^ d Μ A群2。將其以 適切的二個限制酶切斷則可取得c D n A片斷群3。根據 此c D . N A兩終端之各2個驗基、全部4個鹼基之序列, 即’根據此些序列爲腺嘌哈(以下簡稱爲A )、鳥嘌哈( 以下簡稱爲G )'胞嘧啶(以下簡稱爲c )或胸腺嘧啶( 以下簡稱爲T )之任一種予以分類。即,根據5,終端( 圖1中以黑色表現)之鹼基首先分類成4個集團4。其爲 根據下一驗基再分類成1 6個集團5,再根據3,終端之 第2個驗基分類成6 4個集團6,且再根據3,終端之鹼 基分類成2 5 6個之集團7。若由一般的表現mRNA種 類推測,則於最終所得的2 5 6個集團7中,分別含有約 8 0至約1 0 0種的c D N A。即,若將各個集團進行電 泳,則可檢測出約8 0個至約1 〇 〇個之波峰。因此,由 特定細胞所得之全m R N A爲以具有約8 0至約1 0 0個 波峰之2 5個圖表型式表現。即,根據此2 5 6個圖表, 構成所表現基因的解析圖。例如,此類解析圖中所含之一 個圖表例爲如圖3所示。圖3之圖表爲示出於片斷之分類 後,將各餾分以P C R予以放大,將反應產物進行電泳所 得之一餾分中所含成分的圖表。 又,本發明特徵之一爲將表現m R N A所得之 c D ΝΑ使用適切的二種限制酶,較佳爲M s ρ Ϊ和 M s e I予以適切地切斷。經由適切地切斷,則可達成上 述分類。以下,更詳細說明本發明。 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -10- 1237663 Α7 Β7 五、發明説明(8 ) 2 詳細說明 (1 )基因表現解析圖 製作本發明基因表現解析圖之方法基本上爲具備以下 工程。即, (a )對於由細胞所萃取之m R N A ’合成其3 終 端加成標的物質之c D N A之工程, (b )將所得之反應產物以第一限制酶x予以切斷之 工程, (c )將具有對第一限制酶X之限制酶切斷部位之序 列呈互補性序列的X適應子,對於工程b所得之片斷進行 結合之工程, (d )經由對該標的物質結合具有高親和性之物質’ 則可回收工程c所得片斷之工程, (e )將工程d所回收之片斷以第二限制酶Y予以切 斷,除去結合至該標的物質之片斷,則可取得含有經切斷 c D N A 5 ’側片斷之工程, (f )對於工程e所得之片斷’將具有對第二限制酶 Y辨識切斷部位之序列呈互補性序列之Y適應子予以加成 之工程, (g )使用對該X適應子序列具有互補性序列且其 3 ’終端具有任意二個鹼基序列N N之引子’與對該γ適 應子序列具有互補性序列且其3 ’終端具有任意二個鹼基 序列N N之引子,並對於前述工程ί所得之片斷進行 P C R反應之工程, 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) (請先閲讀背面之注意事項再填寫本頁)1237663 A7 B7 V. Description of the invention (1) (Please read the notes on the back before filling this page) This application is based on Japanese Patent Application No. 2 0 〇〇— filed on February 12, 2012 No. 3 7 7 8 8 7 and claims priority based on the application. This application is incorporated into this specification by reference. (Technical Field) The present invention relates to a method for generating a gene expression analysis map and a method for analyzing a gene expression frequency. [Background Art] In 2000, the entire sequence of the human genome was continuously determined. The huge amount of data obtained from this is the basis for a comprehensive understanding of the networks that contain these gene products in all genes and specific cells. The methods used to explain such networks are as follows. For example, the Differential Display method disclosed in US5262311 and US5599672, and the sequential analysis method of genetic performance disclosed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs and the Ministry of Economic Affairs printed 1 0-5 1 1 0 0 2 ( That is, serial analysis of gene expression (hereinafter referred to as SAGE), and the microarrays and DNA fragments disclosed in USP 5807522, USP 5700637 and USP 5744305. The classification display method is a method using c D N A prepared by cells as a substrate. With respect to c D N A, various arbitrary gene expressions in a cell can be analyzed by performing PCR using plural types of anchor primers and arbitrary primers. However, this method is only a part of the analysis of all genes. The paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) -4- 1237663 A7 B7 V. Description of the invention (2). In addition, the use of anchor primers and arbitrary primers has a problem of lack of reproducibility. (Please read the notes on the back before filling out this page.) In contrast, the method for obtaining a performance analysis map of all-expressing genes in a cell is SAG E. S A G E is analyzed using c D N A modulated by m R N A modulated by the cell. The adjusted c DNA was subjected to restriction enzyme treatment, a fragment of about 9 to 11 base pairs was cut out, and fragments from various c D N A were ligated, and then sequenced. However, in SAGE, in order to obtain data of about 50% of the full-expression genes, a sequence of about 100,000 cycles must be performed, which makes the cost very high. In addition, fragments from cDNA are short, and in fact, it is impossible to isolate genes from the fragments. The microarray of US 5 8 0 7 5 2 2 and the D N A fragments of USP 5700637 and USP 5744305 are used to immobilize probes of known genes in the solid phase. By hybridizing the sample with this probe, a method for analyzing the expression of genes can be obtained. In these methods, the sequence of the gene to be detected must be known. Printed by the Employees' Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs [Disclosure of the Invention] The first object of the present invention is to provide a method for generating a performance analysis map of a gene in a wide range. A second object of the present invention is to provide a method for analyzing the expression frequency of a wide range of genes. The above-mentioned first purpose is to create a method for analyzing the expression of genetic expressions, which is to have the paper size applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) -5- 1237663 A7 B7 V. Description of the invention (3) ( a) For the process of m RNA extracted from cells to synthesize c DNA of its 3 'terminal addition target substance, (b) the process of cutting the obtained reaction product with the first restriction enzyme X, (c) the process of The X aptamer having a complementary sequence to the sequence of the restriction enzyme cutting site of the first restriction enzyme X is used to combine the fragments obtained in the engineering b, (d) by binding a substance having a high affinity to the target substance 'Then the process of recovering the fragment obtained from project c can be recovered. (E) The fragment recovered from project d can be cut with the second restriction enzyme Y, and the fragment containing the cleaved c DNA can be obtained. 5 The project of 5 side fragments, (f) For the fragment obtained from project e, a project in which a Y aptamer having a complementary sequence to the sequence of the second restriction enzyme Y recognition cut site is added, (g) using the X adaptor sequences have A primer with a complementary sequence and its 3 'terminal with any two base sequence NN, and a primer with a complementary sequence to the Y adaptor sequence and its 3' terminal with any two base sequence NN, and for the aforementioned project f. The obtained fragment is subjected to a PCR reaction project. (h) The obtained PCR product is subjected to electrophoresis, and a method of preparing a gene expression analysis map can be achieved by detecting a moving distance and a wave peak. The above second purpose is to analyze the frequency of gene expression, which is based on the Chinese paper standard (CNS) A4 specification (210 × 297 mm). (Please read the precautions on the back before filling this page) Order the wisdom of the Ministry of Economic Affairs Printed by the Consumer Cooperative of the Property Bureau • 6-1237663 A7 B7 V. Description of the invention (4) Yes (Please read the precautions on the back before filling this page) (a) For both control cells and test cells, use the above production The method of gene expression analysis chart, the process of making the gene expression analysis chart, (b) the method of analyzing the change of the gene expression frequency of the tested cells can be achieved by comparing the two gene expression analysis charts obtained by comparison. Still other objects and advantages of the present invention are described in the following description and examples. Based on these records and examples, the present invention can be understood more clearly. In addition, the objects and advantages of the present invention can be explained in detail and achieved through the methods and combination means shown below. (Brief description of the drawings) The drawings incorporated in this specification and forming a part of it are necessarily detailed descriptions of the preferred aspects of the present invention, as well as the above general descriptions and preferred aspects described later. It is to explain the basic idea of the present invention for use. Fig. 1 is a schematic diagram showing a method of making a gene expression analysis map according to an aspect of the present invention. Printed by the Consumer Cooperative of Intellectual Property Bureau of the Ministry of Economic Affairs Fig. 2 is a flow chart showing a method of making a genetic expression analysis map according to an aspect of the present invention. Fig. 3 is a diagram showing an example of a part of a gene expression analysis map obtained according to an aspect of the present invention. FIG. 4 is a combination diagram showing arbitrary two base sequences. Fig. 5 is a diagram showing the proportion of genes detected in the analysis map of gene expression according to aspects of the present invention. This paper size applies the Chinese National Standard (CNS) A4 specification (21.0X297 mm) 1237663 A7 B7 V. Description of the invention (5) Figure 6 is a diagram showing a preferred example of the X adaptor and the Y adaptor. (Please read the precautions on the back before filling this page.) Figure 7 shows a partial gene sequence diagram of human arylamine N-acetamidine transferase obtained from the database. FIG. 8 is a diagram showing an example of data about fragments obtained by restriction enzymes. Fig. 9 is a partial diagram showing an example of a gene expression analysis diagram showing the expression of P 2 1. Fig. 10 is a partial diagram of an example of a gene expression analysis diagram showing m d m 2 expression. Fig. 11 is a partial diagram showing an example of a gene expression analysis diagram showing cyclic G expression. FIG. 12 is a diagram showing the composition of the m R N A modulator used in Example 2. FIG. FIG. 13 is a partial diagram showing a gene expression analysis map obtained in Example 2. FIG. Fig. 14 is a partial diagram showing a gene expression analysis map obtained in Example 2. Printed by the Consumer Cooperative of Intellectual Property Bureau of the Ministry of Economic Affairs [The best form for implementing inventions] 1 · What is the invention? The inventors and others have discovered that the classification of genes expressed in specific cells can be greatly changed. The complexity and cost-effectiveness of operations in making gene expression analysis maps. On the basis of this finding, we made intensive research, and the result reached the invention. According to one aspect of the present invention, in order to provide a one-time and simple method for producing paper, the Chinese national standard (CNS) A4 specification (210X 297 mm) is applicable. -8-1237663 A7 B7 5. Description of the invention (6) (please first (Read the notes on the back, and then fill out this page.) This is a method for analyzing the expression of a wide range of genes including approximately all genes expressed in specific cells. By recognizing approximately all the genes expressed, more genes can be identified than before. One aspect of the present invention is a genetic expression analysis map method developed based on the restriction enzyme D N A fragment length and the polymerase chain reaction (ie, PCR). Through such a gene expression analysis map method ', almost all the genes represented can be identified, that is, both known genes and unknown genes can be identified as well. In addition, this method does not miss a single gene 'and can be identified and detected separately. In addition, the frequency of its performance can also be determined. Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs. One of the basic features of the method for producing the gene expression analysis map of the present invention is to classify genes expressed in specific cells as follows. The number of mRNAs expressed in a particular cell is considered to be about 20,000. First, c DNA is synthesized from the expressed mRNA. The obtained double-stranded c DNA was cut with appropriate two restriction enzymes to make various fragments having only recognizable lengths. Thereafter, it was classified into 256 fractions which could identify a partial sequence of the obtained fragment. This classification was first performed using 2 5 6 primer sets of arbitrary design. Under the condition that the relative performance is still reflected, the fragment is enlarged in each primer group and the fragment is classified. For classification, the obtained fractions, for example, each of 2 to 6 fractions, are subjected to electrophoresis per fraction to separate the components. In this way, the performance gene data obtained from one cell is classified to the extent that it can be parsed. In this way, it is possible to easily produce almost all genes without missing them, and accurately capture a gene expression analysis map of each gene expression. For example, use Figure 1 to illustrate the specificity of the manual paper grades classified into 2 56 fractions. The national standard (CNS) A4 specification (21〇 × 297 mm) -9-1237663 A7 ___B7 V. Description of the invention ( 7) (Please read the notes on the back before filling out this page) Printed section of the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs. ^ D A A group 2 was synthesized from the expressed m R N A group 1. By cutting it with two appropriate restriction enzymes, the c D n A fragment group 3 can be obtained. According to the sequence of 2 test bases and 4 bases of each terminal of c D. NA, that is, according to these sequences, adenine (hereinafter referred to as A) and guanine (hereinafter referred to as G). Either cytosine (hereinafter referred to as c) or thymine (hereinafter referred to as T) is classified. That is, according to 5, the bases of the terminal (shown in black in FIG. 1) are first classified into 4 groups of 4. It is further classified into 16 groups 5 according to the next test base, and then 3, the second test base of the terminal is classified into 6 4 groups 6, and the base of the terminal is further classified into 2 5 6 according to 3. Group 7 If it is inferred from the general expression mRNA type, the 256 groups 7 finally obtained contain about 80 to about 100 kinds of c D N A, respectively. That is, if each group is subjected to electrophoresis, about 80 to about 1000 peaks can be detected. Therefore, the total m R N A obtained from a specific cell is represented by 25 graph patterns having about 80 to about 100 peaks. That is, from these 256 graphs, an analysis graph of the expressed genes is constructed. For example, an example of a chart contained in such an analysis diagram is shown in Figure 3. The graph of Fig. 3 is a graph showing the components contained in one fraction obtained by fractionating the fractions, magnifying the fractions by PCR, and electrophoresing the reaction product. In addition, one of the characteristics of the present invention is that c D ΝA obtained by expressing m R N A is appropriately cut using two appropriate restriction enzymes, preferably M s ρ Ϊ and M s e I. By appropriate cutting, the above classification can be achieved. Hereinafter, the present invention will be described in more detail. This paper scale applies Chinese National Standard (CNS) A4 specification (210X297 mm) -10- 1237663 A7 B7 V. Description of the invention (8) 2 Detailed description (1) Gene expression analysis chart The method for making the gene expression analysis chart of the present invention is basically The above is equipped with the following works. That is, (a) a process for synthesizing c DNA of a 3-terminal addition target substance from m RNA extracted from a cell, (b) a process for cutting the obtained reaction product with a first restriction enzyme x, (c ) An engineering process in which an X aptamer having a complementary sequence to the restriction enzyme cutting site of the first restriction enzyme X is combined with the fragment obtained in the engineering b, (d) has a high affinity for binding to the target substance Substances' can be recovered in the process of the fragment obtained from the project c, (e) the fragment recovered in the process d is cut with a second restriction enzyme Y, and the fragment containing the cut substance c can be obtained by removing the fragment bound to the target substance Project of DNA 5 'side fragment, (f) For the fragment obtained from project e', a project in which a Y aptamer having a complementary sequence to the sequence of the second restriction enzyme Y recognition cut site is added, (g) is used A primer having a complementary sequence to the X aptamer sequence and its 3 'terminal having an arbitrary two base sequence NN' and a complementary sequence to the γ adaptor sequence and an arbitrary two base sequence to its 3 'terminal NN Primer and for The project for the PCR reaction of the fragment obtained from the previous project, this paper size applies the Chinese National Standard (CNS) A4 specification (210 X 297 mm) (Please read the precautions on the back before filling this page)

、1T 經濟部智慧財產局員工消費合作社印製 -11 - 1237663 A7 B7 五、發明説明(9 ) (h )將所得之p C R產物進行電泳,經由檢測移動 距離和波峰,製作基因表現解析圖之工程。 此處’雖無特別限定,但將意義鏈(與做爲模板之 m R N A爲相同之序列)之5 ’側視爲雙股c D N A的 5 ’側,意義鏈之3 ’側視爲雙股c D N A的3,側。 使用圖2說明製作本案發明之基因表現解析圖方法的 具體例。此處,圖2中各字母爲表示構成鹼基序列的鹼基 ° A爲表示腺嘌呤(以下簡稱爲a ) ,g爲表示鳥嘌呤(Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs, 1T-1237663 A7 B7 V. Description of the invention (9) (h) The electrophoresis of the obtained p CR product, through the detection of the moving distance and the wave peak, the analysis of the gene expression is made. engineering. Here, although not particularly limited, the 5 'side of the sense strand (the same sequence as the mRNA of the template) is regarded as the 5' side of the double-stranded c DNA, and the 3 'side of the sense strand is regarded as the double-stranded c 3, side of DNA. A specific example of a method for generating a gene expression analysis map of the present invention will be described with reference to FIG. 2. Here, each letter in FIG. 2 represents the base constituting the base sequence ° A represents adenine (hereinafter abbreviated as a), and g represents guanine (

以下簡稱爲G ) 、C爲表示胞嘧啶(以下簡稱爲G )及T 爲表示胸腺嘧啶(以下簡稱爲T )。又,此處,N、W、 X、Y及Z爲表示任意的鹼基。又,X和γ、及w和Z爲 相互互補性地結合。又,上述工程(a )至工程(h )之 工程與圖2中之工程3至工程h爲分別以各個字母對應。 首先,由做爲試驗對象之特定細胞萃取m R N A 1 1 ο 將所萃取之m R N A 1 1之3,終端聚Α尾端互補性 的寡d T引子,以生物素1 3予以標幟化。將其使用做爲 引子,合成c D N A,取得雙股1 2 (圖2,工程a )。 此處,示出使用生物素做爲標的物質之例。 將雙股1 2使用四鹼基辨識限制酶μ s p I做爲第一 限制酶X予以切斷(圖2,工程b )。此處,示出使用 M s p I做爲第一限制酶X之例。 其後,使用鏈霉抗生物素蛋白1 4捕捉生物素1 3。 藉此,捕捉經切斷之雙股c D Ν Α的3,側(圖2 ,工程 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公釐) (請先閲讀背面之注意事項再填寫本頁) 衣·Hereinafter referred to as G), C is referred to as cytosine (hereinafter referred to as G) and T is referred to as thymine (hereinafter referred to as T). Here, N, W, X, Y, and Z represent arbitrary bases. X and γ and w and Z are mutually complementary. In addition, the above-mentioned projects (a) to (h) and the projects 3 to h in FIG. 2 correspond to each letter, respectively. First, m R N A 1 1 ο was extracted from a specific cell as a test object. The extracted m R N A 1 1 3, the terminal poly A tail complementary oligo-d T primers, were labeled with biotin 1 3. This was used as a primer to synthesize c D N A to obtain double strands 1 2 (Figure 2, Project a). Here, an example using biotin as a target substance is shown. The double-stranded 12 was cut using the four-base recognition restriction enzyme μ s p I as the first restriction enzyme X (FIG. 2, project b). Here, an example using M s p I as the first restriction enzyme X is shown. Thereafter, streptavidin 14 was used to capture biotin 13. This captures the 3, side of the cut double strand c D Ν Α (Figure 2, the paper size of this project applies the Chinese National Standard (CNS) A4 specification (210 × 297 mm)) (Please read the precautions on the back before (Fill in this page)

、1T 經濟部智慧財產局員工消費合作社印製 -12- 1237663 A7 B7 五、發明説明(10) c )。此處,示出使用鏈霉抗生物素蛋白做爲對標的物質 具有高親和性之物質例。 於所回收之雙股c D N A的5,側,結合對第一限制 酶X,即,M s p I之辨識切斷部位具有互補性序列的X 適應子15 (圖2,工程d)。 將其使用第二限制酶Y之限制酶M s e I予以切斷( 圖2,工程e )。此處,示出使用M s e I做爲第二限制 酶Y之例。 其次,附加對限制酶Y,即,M s e I之辨識切斷部 位具有互補性序列之Y適應子1 6 (圖2,工程f )。經 由以上之處理,則可構築於該雙股兩終端含有已知序列的 雙股序列1 7。 其次,使用此雙股序列1 7做爲模板,並使用經螢光 色素標幟之雙股D N A的5 ’側(反意義鏈用)P C R引 子1 8,與不具有螢光標幟之雙股c D N A的3,側(意 義鏈用)引子19,進行PCR反應(圖2,工程g)。 此處,前述P CR用之X引子1 8及Y引子1 9爲分別使 用對前述適應子,即X適應子及Y適應子之序列呈互補性 序列,與於放大之方向再具有2個鹼基的序列。前述任意 之2個鹼基,因爲設計成含有由A、G、C及T四種鹼基 組合所得之全部序列,故可取得合計2 5 6種之引子組。 即,使用此些引子組,對於全部該雙股c D N A進行 P CR ’則可將存在之全部c DNA分類成2 5群並且可 同時進行P C R放大。該引子組之任意共計四鹼基組合示 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) f請先閲讀背面之注意事項再填寫本頁;> -訂 經濟部智慧財產局員工消費合作社印製 -13- 1237663 A7 B7 五、發明説明(1〇 於圖4。圖4中記載AA — AA至ΤΑ — GA爲止之組合 〇 (請先閱讀背面之注意事項再填寫本頁) 於最終工程之圖1工程h中,令所得之2 5 6個餾分 之P C R產物進行電泳,測定波峰,取得基因表現解析圖 (圖1 ,工程h )。將所得2 5 6個餾分中之一個餾分予 以電泳時所得之結果例如取得圖3所示之圖表。縱軸中, 示出以螢光強度做爲指標之表現量。橫軸中,示出以電泳 之移動距離做爲指標之分子量。 又,亦可將前述工程c和工程d之順序更換。即,前 述工程d亦可於工程c前進行。 更且,將第一限制酶做爲第二限制酶,並將第二限制 酶使用做爲第一限制酶,則可對於更多基因進行切斷,藉 .此可提高檢測感度。 經濟部智慧財產局員工消費合作社印製 即,將上述工程a所得之雙股1 2分成二群,以 c D N A混合物A和c D N A混合物B,對於c D N A混 合物A如上述進行工程b至h,與其並行或依序地,對於 c D N A混合物B亦可進行如下之處理。即,c D N A混 合物B爲使用限制酶M s e I做爲第一限制酶,且使用限 制酶M s p I做爲第二限制酶,其他點爲與上述方法同樣 處理。如此,經由將第一限制酶與第二限制酶交換使用, 則對於未交換時無法檢測出之基因亦可進行檢測。 c DNA混合物Β之處理具體而言爲將c DNA混合 物Β中所含之雙股1 2,使用四鹼基辨識限制酶M s e I 予以切斷。其後,結合對限制酶M s e I之辨識切斷部位 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) ' '"— -14- 1237663 Α7 Β7 五、發明説明(d (請先閱讀背面之注意事項再填寫本頁) 具有互補性序列之M s e I適應子,使用鏈霉抗生物素蛋 白捕捉生物素,回收經切斷之雙股1 2的3 ’側。其次, 將其使用限制酶M s p I予以切斷。其後,附加於限制酶 M s ρ I之辨識切斷部位具有互補性序列的M s ρ I適應 子。經由以上之處理,構築於該雙股1 2之兩終端含有已 知序列的序列。其次,對於此序列,使用經螢光色素標幟 之X引子1 8,與不具有螢光標幟之Υ引子1 9,對於 cDNA進行P CR反應。此處,前述二個引子1 8及 1 9爲分別使用對該適應子,即,Y適應子及X適應子呈 互補性序列,加上於放大方向再附加2個鹼基之物質。所 附加之任意的2個鹼基,因爲設計成含有由A、G、C及 T四種鹼基組合所得之全部序列,故可取得合計2 5 6種 引子組(圖2工程a至工程f ,具體的2 5 6種N N — 經濟部智慧財產局員工消費合作社印製 N N驗基序列爲示於圖4 )。即,使用此些引子組,對於 全部之c D N A進行P C R,則可將存在之全部種類的 c DNA分類成2 5 6群。令所得之2 5 6群PCR產物 進行電泳,並且測定移動距離和波峰則可取得基因表現解 析圖。 根據本發明態樣之方法所分類之表現基因爲如圖5所 示般,例如於鼠之情況,隨意選出1 0 0個鼠之約8 5 % 基因爲被識別檢出。即,使用M s ρ I做爲第一限制酶且 使用M s e I做爲第二限制酶之情形中,經表現之基因的 約6 6 %爲被切斷。使用M s e I做爲第一限制酶,且使 用M s ρ I做爲第二限制酶之情形中,經表現之基因的約 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) -15- 1237663 A7 B7 五、發明説明(13) (請先閲讀背面之注意事項再填寫本頁) 1 9 %爲被切斷。因此,經由將第一限制酶與第二限制酶 交換,則全體爲經表現之基因的約8 5 %爲被識別檢出。 藉此,可更正確製作基因解析圖。先前方法所識別之基因 比例通常爲2 0至3 0%,最高爲5 0%。因此,根據本 發明態樣所作成之基因表現解析圖中所識別之基因比例, 爲比先前之比例更加大幅提高。理論上可稱爲幾乎完全可 辨識1細胞中所含的基因。 此處所使用之「基因表現解析圖」用語,爲表示於某 條件下於特定細胞中之基因表現型式,包含公知及未知基 因表現之有無,所表現之全部基因的表現量等資料。又, 該基因表現解析圖可使用做爲解析基因表現之手段。 此處所使用之「聚A尾部」爲指一般亦稱爲聚A的 m R N A之3 ’終端序列。又,經由對聚A尾部具有互補 性序列之「寡d T引子」’則可由具有該聚A尾部之 mRNA合成c DNA。此處所使用之「寡dT引子」一 般亦稱爲寡(dT)引子。以寡dT引子合成cDNA, 可根據一般所進行的任何條件予以達成。 經濟部智慧財產局員工消費合作社印製 此處所使用之「標的物質」及「對標的物質具有高親 和性之物質」爲指彼此具有高親和性且構成可專一性結合 之結合對之一者之物質。上述之項目,即,於「( 1 )基 因表現解析圖」中所記載之例中,雖使用生物素做爲標的 物質、鏈霉抗生物素蛋白做爲對標的物質具有高親和性之 物質,但並非限定於此。若爲彼此具有高親和性且可專一 性結合,即可使用。本發明中可使用之標的物質和對標的 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) ' ~~ -16 - 1237663 A7 _____ B7__ 五、發明説明(Μ) (請先閲讀背面之注意事項再填寫本頁) 物質具有高親和性之物質組合例爲包含生物素與鏈霉抗生 物素蛋白、生物素與抗生物素蛋白、F I TC與F I TC 抗體、D I G與抗D I G、蛋白質A與鼠I gG、及膠乳 粒子等,但並非限定於此。又,於各組合中,可使用任一 者做爲標的物質,且可使用任一者做爲對標的物質具有高 親和性之物質。 經濟部智慧財產局員工消費合作社印製 此處所使用之「限制酶」,一般爲亦被稱爲限制內核 酶之酵素,於特定之序列中將雙股D N A予以水解切斷之 酵素。根據本發明態樣之方法中,爲了取得適切之片斷乃 組合使用二種限制酶X及Y。本發明中可使用之限制酶, 以可將表現基因之m R N A所合成之c D N A所組成的雙 股,切斷成具有可識別長度之片斷的酵素爲佳。又,以所 得之該雙股切斷成更多,較佳爲將幾乎完全之雙股予以切 斷之酵素爲佳。此類酵素例示於表1。由表1之酵素選出 任何二種,組合使用亦可。又,表1所示之酵素爲四鹼基 辨識酵素,但其他四鹼基辨識酵素,或六鹼基辨識酵素亦 可使用。特別,於根據本發明態樣之方法中,以使用四鹼 基辨識酵素爲佳,且更佳爲組合使用M s p I和M s e I 。於上述例中,使用M s p I (或M s e I )做爲限制酶 X、MseI (或MspI)做爲限制酶Y。 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) -17- 1237663 A7 B7 五、發明説明(15) 經濟部智慧財產局員工消費合作社印製Printed by 1T Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs -12-1266366 A7 B7 V. Description of Invention (10) c). Here, examples of substances having high affinity using streptavidin as a target substance are shown. On the 5, side of the recovered double-stranded c D N A, an X adaptor 15 having a complementary sequence to the recognition restriction site of the first restriction enzyme X, that is, M s p I (FIG. 2, project d) is bound. It was cut using the restriction enzyme M s e I of the second restriction enzyme Y (FIG. 2, process e). Here, an example using M s e I as the second restriction enzyme Y is shown. Secondly, a Y aptamer 16 having a complementary sequence to the restriction enzyme Y, that is, the recognition cut-off site of M s e I was added (Fig. 2, project f). After the above processing, a double-stranded sequence 17 containing a known sequence can be constructed on the double-stranded two-terminal terminal. Next, use this double-stranded sequence 17 as a template, and use the 5 ′ side (for antisense strand) PCR primers 18 of the double-stranded DNA labeled with fluorescein and the double-stranded c without fluorescent marker. The 3, side (for sense strand) primer 19 of the DNA was subjected to a PCR reaction (Fig. 2, engineering g). Here, the X primers 18 and Y primers 19 for the P CR are complementary sequences to the sequences of the aforementioned aptamers, that is, the X and Y adaptors, respectively, and have 2 bases in the direction of amplification. Base sequence. The arbitrary two bases mentioned above are designed to contain all sequences obtained by combining four bases of A, G, C, and T, so that a total of 2 56 types of primer sets can be obtained. That is, using these primer sets, performing P CR ′ on all the double-stranded c D N A can classify all the existing c DNA into 25 groups and perform PCR amplification at the same time. Any four-base combination of this primer set indicates that the paper size is applicable to Chinese National Standard (CNS) A4 (210X297 mm) f Please read the notes on the back before filling this page; >-Order the Intellectual Property Bureau of the Ministry of Economic Affairs Printed by Employee Consumer Cooperatives-13-1237663 A7 B7 V. Description of the invention (10 is shown in Figure 4. The combination of AA — AA to TA — GA is recorded in Figure 4 (please read the precautions on the back before filling this page) In the final project of Figure 1, Project h, the obtained PCR products of 256 fractions were subjected to electrophoresis, and the peaks were measured to obtain an analytical map of gene performance (Figure 1, Project h). One of the obtained 256 fractions The results obtained when the fractions are subjected to electrophoresis are obtained, for example, in the graph shown in Fig. 3. The vertical axis shows the expression amount using the fluorescence intensity as an index. The horizontal axis shows the molecular weight using the moving distance of the electrophoresis as an index. In addition, the order of the aforementioned project c and project d may be changed. That is, the aforementioned project d may also be performed before the project c. Furthermore, the first restriction enzyme is used as the second restriction enzyme, and the second restriction enzyme is used. As the first restriction enzyme, More genes can be cut off, which can improve the detection sensitivity. Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs, the double strands 12 obtained from the above project a are divided into two groups, c DNA mixture A and c For DNA mixture B, for c DNA mixture A, the processes b to h are performed as described above, and in parallel or sequentially, c DNA mixture B can also be processed as follows. That is, c DNA mixture B is made using the restriction enzyme M se I Is the first restriction enzyme, and the restriction enzyme M sp I is used as the second restriction enzyme, and the other points are treated in the same manner as above. In this way, by using the first restriction enzyme and the second restriction enzyme interchangeably, Genes that cannot be detected can also be detected. Specifically, the treatment of c DNA mixture B is to cleave the double strands 12 contained in c DNA mixture B using a four-base recognition restriction enzyme M se I. Combined with the identification of the restriction enzyme M se I, the cut size of this paper applies the Chinese National Standard (CNS) A4 specification (210X297 mm) '' " — -14- 1237663 Α7 Β7 5. Description of the invention (d (please first Read back (Notes on this page, please fill out this page again)) M se I aptamers with complementary sequences, use streptavidin to capture biotin, and recover the 3 'side of the double stranded strand 12. Second, limit its use The enzyme M sp I is cut off. Then, an M s ρ I aptamer with a complementary sequence is added to the recognition cut site of the restriction enzyme M s ρ I. After the above processing, the double stranded 12 2 is constructed. The terminal contains a sequence of a known sequence. Second, for this sequence, a PCR reaction was performed on the cDNA using X primer 18 marked with a fluorescent pigment and 19 primers without a fluorescent marker. Here, the aforementioned two primers 18 and 19 are substances in which the aptamer, that is, the Y aptamer and the X aptamer have complementary sequences, and are added with two bases in the amplification direction. The additional two bases are designed to contain the entire sequence of four base combinations of A, G, C, and T, so a total of 2 5 6 primer sets can be obtained (Figure 2 project a to project f The specific 2 5 6 kinds of NNs — the printed NN test sequence of the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs are shown in Figure 4). That is, by using these primer sets to perform P C R on all c D N A, all types of c DNA existing can be classified into 2 5 6 groups. The obtained 256-group PCR products were subjected to electrophoresis, and the moving distances and wave peaks were measured to obtain a gene expression analysis map. The expression genes classified according to the method of the present invention are as shown in FIG. 5, for example, in the case of mice, about 85% of the genes of 100 rats are randomly selected for identification and detection. That is, in the case where M s ρ I is used as the first restriction enzyme and M s e I is used as the second restriction enzyme, about 66% of the expressed genes are cut off. In the case where M se I is used as the first restriction enzyme and M s ρ I is used as the second restriction enzyme, the approximate paper size of the expressed gene applies the Chinese National Standard (CNS) A4 specification (210X297 mm) -15- 1237663 A7 B7 V. Description of the invention (13) (Please read the precautions on the back before filling in this page) 19% is cut off. Therefore, by exchanging the first restriction enzyme and the second restriction enzyme, about 85% of the expressed genes as a whole are detected and detected. Thereby, a gene analysis map can be made more accurately. The percentage of genes identified by previous methods is usually 20 to 30%, with a maximum of 50%. Therefore, the proportion of genes identified in the analysis map of gene expression made according to the aspect of the present invention is much higher than the previous proportion. Theoretically, it can be said that the genes contained in 1 cell can be almost completely identified. The term "analysis map of gene expression" as used herein refers to the gene expression pattern in a specific cell under certain conditions, and includes information on the presence or absence of known and unknown gene expression, and the expression amount of all genes expressed. The gene expression analysis map can be used as a means for analyzing gene expression. The "poly A tail" as used herein refers to the 3 'terminal sequence of m R N A, also commonly referred to as poly A. In addition, cDNA can be synthesized from an mRNA having the polyA tail via an "oligod T primer" having a complementary sequence to the polyA tail. The "oligo dT primer" used herein is also commonly referred to as an oligo (dT) primer. Synthesis of cDNA with oligo-dT primers can be achieved under any conditions generally performed. The "subject matter" and "substances with high affinity to the target substance" printed here by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs refer to those who have high affinity with each other and constitute a specific combination. substance. The above item, that is, in the example described in "(1) Gene expression analysis map", although biotin is used as the target substance and streptavidin is used as the target substance, the substance has high affinity, But it is not limited to this. They can be used as long as they have a high affinity for each other and can bind specifically. The target substance that can be used in the present invention and the standard paper size are applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) '~~ -16-1237663 A7 _____ B7__ V. Description of the invention (M) (Please read the back first (Please fill in this page before filling in this page) Examples of substance combinations with high affinity include biotin and streptavidin, biotin and avidin, FI TC and FI TC antibodies, DIG and anti-DIG, proteins A and rat I gG, and latex particles are not limited thereto. In each combination, any one can be used as a target substance, and any one can be used as a substance having a high affinity for the target substance. Printed by the Employees' Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs. The "restriction enzymes" used here are generally enzymes that are also known as restriction kernel enzymes. They are enzymes that hydrolyze and cut off double-stranded DNA in a specific sequence. In the method according to the aspect of the present invention, two restriction enzymes X and Y are used in combination in order to obtain a suitable fragment. The restriction enzyme that can be used in the present invention is preferably an enzyme that can cleave a double strand composed of c D N A synthesized by m R N A expressing a gene into a fragment having a recognizable length. In addition, the obtained double strand is cut into more, preferably an enzyme that cuts almost the complete double strand. Examples of such enzymes are shown in Table 1. Any two enzymes are selected from the enzymes in Table 1, and they can be used in combination. The enzymes shown in Table 1 are four base recognition enzymes, but other four base recognition enzymes or six base recognition enzymes may be used. In particular, in the method according to the aspect of the present invention, it is preferable to use a tetrabasic recognition enzyme, and more preferably to use M s p I and M s e I in combination. In the above example, M s p I (or M s e I) is used as the restriction enzyme X, and MseI (or MspI) is used as the restriction enzyme Y. This paper size applies to China National Standard (CNS) A4 (210X 297 mm) -17- 1237663 A7 B7 V. Description of Invention (15) Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs

表1 Acc II c0yco Hpa II C/CGG AT8I QT/AC Ηδρ92 II CATO/ Alul AG/CT HtpAI G/CGC AspLEI 6CG/C kzofil /GATC Bfal C/TAG Mae I C/TAG BscFI /GATC Mbol /GATC Beh12361 CGJCG Msel T/TAA Bshl GQ/CC Msp I (^CGG BsiS! C/CGG Mvnl CG/CG Ββρ143I /GATC Nde II /GATC BstU I CQ/CQ Nla III CATO/ BsuFU GQ/CC Pall QO^CC C切I OOQIC Rsal GT/AC CspBI G/TAC Seu3A 1 /QATb Wpn II Mat。 幺 se91 /AATT FnuD II co/co Taql T7CQA Hae III 6G/CC Thai C0/CQ Hap II C/C^G Trull ΤΑΓΑΑ Hhal GCG/C TruSI T/TAA Hin2l C/CGO Tip5091 /AATT Hin6 册 G/CGC TspE 1 /AATT HinP11 O/CGC TthHBB 1 T/CQA (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) -18- 1237663 Α7 Β7 五、發明説明(16) (請先閱讀背面之注意事項再填寫本頁) 此處所使用之「適應子」爲使用於將最終p c R放大 時所用之引子予以結合者。所使用之適應子爲根據所使用 之限制酶而設計。即,結合限制酶X之辨識切斷部位的X 適應子,爲含有對限制酶X之辨識切斷部位呈互補性序列 ,且再亦可具有任意之序列。再任意序列及鹼基之長度可 考慮P C R之效率而設計。較佳爲將X適應子設計成1 5 個鹼基左右。如此可進行安定的p c R。結合限制酶Y之 辨識切斷部位的Y適應子,爲含有對限制酶Y之辨識切斷 部位呈互補性序列,且再亦可具有任意之序列。再任意序 列及鹼基之長度可考慮P C R之效率等而設計。較佳爲將 Y適應子設計成1 5個鹼基左右。如此可進行安定的 P C R 〇 例如,使用M s p I做爲限制酶X時之較佳的X適應 子序列示於圖6 ( a ),使用M s e I做爲限制酶X時之Table 1 Acc II c0yco Hpa II C / CGG AT8I QT / AC Ηδρ92 II CATO / Alul AG / CT HtpAI G / CGC AspLEI 6CG / C kzofil / GATC Bfal C / TAG Mae IC / TAG BscFI / GATC Mbol / GATC Beh12361 CGJCG Msel T / TAA Bshl GQ / CC Msp I (^ CGG BsiS! C / CGG Mvnl CG / CG Ββρ143I / GATC Nde II / GATC BstU I CQ / CQ Nla III CATO / BsuFU GQ / CC Pall QO ^ CC C Cut I OOQIC Rsal GT / AC CspBI G / TAC Seu3A 1 / QATb Wpn II Mat. 幺 se91 / AATT FnuD II co / co Taql T7CQA Hae III 6G / CC Thai C0 / CQ Hap II C / C ^ G Trull ΤΑΓΑΑ Hhal GCG / C TruSI T / TAA Hin2l C / CGO Tip5091 / AATT Hin6 Book G / CGC TspE 1 / AATT HinP11 O / CGC TthHBB 1 T / CQA (Please read the precautions on the back before filling this page) This paper standard is applicable to Chinese National Standard (CNS) A4 specifications (210X 297mm) -18-1237663 Α7 Β7 V. Description of the invention (16) (Please read the precautions on the back before filling this page) The "adaptor" used here is used to enlarge the final pc R The primers used at the time are bound. The adapter used is designed based on the restriction enzyme used. That is, the binding limit The X aptamer of the recognition cut site of enzyme X contains a complementary sequence to the recognition cut site of restriction enzyme X, and may also have an arbitrary sequence. Furthermore, the efficiency of PCR can be considered for any sequence and the length of the base. And the design. It is better to design the X adaptor to about 15 bases. In this way, stable pc R can be carried out. The Y adaptor combined with the restriction enzyme Y recognition cutting site contains the recognition enzyme for restriction enzyme Y. The broken site is complementary, and it can have any sequence again. The arbitrary sequence and the length of the base can be designed considering the efficiency of PCR, etc. It is better to design the Y adaptor to about 15 bases. Stable PCR can be performed. For example, the preferred X adaptor sequence when M sp I is used as the restriction enzyme X is shown in FIG. 6 (a), and when M se I is used as the restriction enzyme X,

較佳的X適應子序列示於圖6 ( b )。又,使用M s p I 做爲限制酶Υ時之較佳的Υ適應子序列示於圖6 ( c ) ’ 經濟部智慧財產局員工消費合作社印製 使用M s e I做爲限制酶Υ時之較佳的Υ適應子序列示於 圖6 ( d )。但是,並非限制於此。 工程g所使用之「引子組」爲由工程f中所得之雙股 c D N A經由P C R放大所使用之一組X和Y引子所構成 。詳言之,爲如上述,此處所使用之「任意之二鹼基序列 N N」爲由腺嘌呤、胸腺嘧啶、鳥嘌呤及胞嘧啶所任意選 出之序列。如上述,以任意之序列做爲二鹼基(即’ N N )時,於1樣品之P C R所得之圖表中,含有約8 0至約 本紙張尺度適用中國國家標準(CNS ) Α4規格(21〇><297公釐) -19- 1237663 A7 B7 五、發明説明(j (請先閱讀背面之注意事項再填寫本頁) 1 0 0個之波峰。此處,以各任意序列做爲二鹼基者,爲 考慮該方法之簡便性和解析精度之結果。因此,於根據本 發明態樣之方法,較佳之各任意序列爲二鹼基N N,較佳 之引子組數爲2 5 6。但是,並不限定於此。該二個引子 中所分別含有之任意的二鹼基序列N N,對於任一引子( X或Y引子)或兩者引子(X及Y引子)亦可作成三鹼基 以上。如此可增加引子組中所含之引子種類。此時,所得 之餾分分別爲1024或4〇96。 又,若根據本發明之態樣,則爲了令P C R後之檢測 容易’較佳於該引子之任一終端預先結合螢光物質。較佳 爲結合至對X適應子具有互補性序列之X引子的5 ’終端 。本發明方法中可使用的螢光物質包含6 -羧基螢光素( 以下,稱爲 FAM)、4,7,2,,4, ,5,,7,— 六氯一6—羧基螢光素(以下,稱爲HEX) 、NED( Applied Biosystems Japan 公司)及 6 —羧基—X —若丹 明(以下,稱爲R 〇 X )等。 經濟部智慧財產局員工消費合作社印製 根:據本發明態樣所實施之P c R反應可於一般進行的 條件下實施。例如,於9 5 t: 1分鐘、(9 5 °C 2 0秒鐘 、6 8 °C 3 0 秒鐘、7 2 °C 1 分鐘)X 2 8 回、6 0 °C 3 0分鐘等條件下進行。 根據本發明態樣可使用的電泳手段,若爲一般可根據 分子量將試料分離之電泳手段即可使用。例如,可使用包 含 Sequencar ABI PRISM 3 10 0( Applied B i o s y s t e m s J a p a η 公司)及 Mega BACE 1 0 0 0 ( 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X撕公釐) -20- 1237663 A7 B7 五、發明説明(18)The preferred X adaptor sequence is shown in Figure 6 (b). In addition, a better adaptor sequence when M sp I is used as a restriction enzyme is shown in Figure 6 (c). The best aptamer sequence is shown in Figure 6 (d). However, it is not limited to this. The "primer set" used in project g is composed of a set of X and Y primers used by the double-stranded c D N A obtained in project f by P C R amplification. Specifically, as described above, the "arbitrary two-base sequence N N" used herein is a sequence arbitrarily selected from adenine, thymine, guanine, and cytosine. As mentioned above, when an arbitrary sequence is used as the two bases (that is, 'NN), the graph obtained by PCR of 1 sample contains about 80 to about this paper size. The Chinese National Standard (CNS) A4 specification (21〇) > < 297 mm) -19- 1237663 A7 B7 V. Description of the invention (j (please read the notes on the back before filling in this page) 100 peaks. Here, two of each sequence are used as two The base is the result of considering the simplicity and accuracy of the method. Therefore, in the method according to the aspect of the present invention, the preferred arbitrary sequence is a two-base NN, and the preferred number of primer sets is 2 5 6. It is not limited to this. The arbitrary two-base sequence NN contained in the two primers can also be made into three bases for any primer (X or Y primer) or both primers (X and Y primer). The above can increase the types of primers contained in the primer set. At this time, the obtained fractions are 1024 or 4096 respectively. In addition, according to the aspect of the present invention, in order to make the detection after PCR easier, it is better than Any terminal of the primer is bound to a fluorescent substance in advance. The 5 'terminal of the X primer having a complementary sequence to the X aptamer. The fluorescent substance that can be used in the method of the present invention includes 6-carboxyfluorescein (hereinafter, referred to as FAM), 4, 7, 2, 2, 4, , 5, 7, 7, hexachloro-6-carboxyfluorescein (hereinafter, referred to as HEX), NED (Applied Biosystems Japan) and 6-carboxy-X-rhodamine (hereinafter, referred to as R OX) Etc. Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs: The P c R reaction implemented according to aspects of the present invention can be performed under normal conditions. For example, at 9 5 t: 1 minute, (9 5 ° C 20 seconds, 6 8 ° C 30 seconds, 7 2 ° C 1 minute) X 2 8 cycles, 60 ° C 30 minutes, etc. The electrophoresis means that can be used according to aspects of the present invention, if It can be used by electrophoresis means that can generally separate samples based on molecular weight. For example, Sequencar ABI PRISM 3 10 0 (Applied Biosystems J apa η) and Mega BACE 1 0 0 0 (This paper size applies to Chinese national standards (CNS) A4 specification (210 X tear mm) -20-1237663 A7 B7 V. Invention (18)

Amersham Pharmacia公司)之一般的電泳裝置。 (3 )波峰之鑑定 (請先閱讀背面之注意事項再填寫本頁) 更且,若根據本發明之態樣,則亦可鑑定如上述所得 之該圖表各波峰中所含的基因。經由鑑定該波峰,則可鑑 定特定狀況中所表現,或,表現量增減的基因。 該基因之鑑定爲經由回收該圖表中之波峰,例如,以 定序列等一般所進行之方法等實驗性手段,並且決定其序 列則可進行鑑定。 又,未使用如上述之實驗性手法,於電腦上,亦可理 論上求出。例如,由一般可使用之數據庫所取得之數據, 並以所使用之限制酶辨識部位和切斷所得片斷之分子量爲 基礎,於電腦上進行鑑定。 經濟部智慧財產局員工消費合作社印製 由數據庫所取得之任意基因序列以特定限制酶切斷時 所得之片斷長度,與該限制酶之辨識部位,可於電腦之顯 示器上輕易決定。另一方面,實際上,本方法所使用之限 制酶切斷所得之片斷長度可經由進行電泳而闡明。因此, 若考慮所使用之適應子序列,則即使不進行實驗性解析, 亦可鑑定該片斷爲來自何種基因。使用電腦之理論性鑑定 法之一例爲於後述實施例1中說明。 又,此處可使用的電腦,可爲一般所使用的電腦,例 如,可使用具備鍵盤及滑鼠等輸入部、印表機及顯示器等 輸出部、C P U等演算部等裝置。 又,可取得數據之數據庫例可列舉 GenBank 、 本紙張尺度適用中國國家標準(cns ) A4規格(21 ox297公釐)~' -21 - 1237663 A7 B7 五、發明説明(19) EMB L及D D B I等之公共的 DataBank 、及商用數 據庫等其他 DataBank之數據,但並非限定於此。 (請先閲讀背面之注意事項再填寫本頁) 又,亦可組合進行實驗性手法和理論性手法兩者。 (4 )基因表現頻率解析 又,根據本發明態樣製作基因表現解析圖之方法中, 被檢細胞所表現之基因表現量爲反映該圖表中所示之各個 波峰之大小。因此,經由觀察該波峰大小之變化,則可解 析基因的表現頻率。 例如,可進行正常細胞與異常細胞之比較、正常細胞 與癌細胞之比較、不同細胞間之比較、及不同條件所處理 之細胞間的比較等。 又,若預先根據本方法,鑑定特定刺激所表現或表現 量變化之基因,則可於其後之試驗中,僅使用關於此特定 基因之引子,即可製作一部分之基因表現解析圖。如此, 則可解析目的基因之表現頻率。 經濟部智慧財產局員工消費合作社印製 實施例1 照射放射線對於P 2 1、m d m 2及C y c 1 i n G表現 量之影響 如下述,檢討照射放射線對於Ρ 2 1 、m d m 2及 cyclin G表現量之影響。使用對於鼠乳癌細胞株S R -1進行放射線照射後所得之m R N A、與未照射之該細胞 所得之m R N A,製作基因表現解析圖,並且比較。 本紙張尺度適用中國國家標準(CNS ) A4規格(21〇'〆297公釐) -22- 1237663 A7 B7 五、發明説明(20) 1 ·基因表現解析圖之製作 實際製作根據本發明態樣之基因表現解析圖。 工一1 mRNA之萃取和cDNA之合成 於7 5 c m 3燒瓶(Falcon公司)中之αΜΕΜ培 養基中,培養鼠乳癌細胞株S R - 1 (由橫濱市大、小山 博士所分得)。對於此細胞,由上方,使用P A N T A C 胃 '津製作所之7 G y照射放射線。照射時間爲3小時。又 ’並行準備未照射細胞做爲對照群。由各個細胞,使用 Fast Track 2 . 0 Kit ( Invitrogen 公司)萃取總 mRNA20微克。 將萃取之2 0微克mRNA於0 . 8微升中與1 0 0 pmole之5’ 一生物素化寡dT引子(BRL公司)混合 ’且於6 5 °C培養5分鐘。冰冷後,將其於逆轉錄緩衝液 20 · 0微升中,與最終濃度5mM之MgCl2和 0 · 5mM之dNTP混合物(BRL公司)和l〇mM 之DTT(BRL公司)共同於42它培養60分鐘。接 著’將其於雙股合成緩衝液1 5 〇 · 〇微升中,與最終濃 度0 · 27 m Μ之dNTP混合物(BRL公司)和 1 · 33mM之DTT (BRL公司)和20 · 0單位之 E. coli連接酶(BRL公司)和40 . 0單位之 E. Coli DNA聚合酶(Brl公司)和2 · 0單位之 RNaseH (BRL公司)共同於16°C培養120分 鐘,其後於7 〇 t培養1 5分鐘,令反應停止。將所得之 本紙張尺度適用中國國家標準(CNS ) A4規格(21〇'乂 297公釐) (請先閲讀背面之注意事項再填寫本頁) 衣·Amersham Pharmacia). (3) Identification of peaks (please read the precautions on the back before filling this page). Furthermore, according to the aspect of the present invention, the genes contained in each peak of the graph obtained as described above can also be identified. By identifying this peak, it is possible to identify genes that are expressed in a specific situation, or that the amount of expression is increased or decreased. The gene can be identified by recovering the peaks in the graph, for example, by experimental methods such as determining the sequence in general, and determining the sequence can be identified. In addition, without using the experimental method described above, it can also be obtained theoretically on a computer. For example, the data obtained from commonly available databases are identified on a computer based on the molecular weight of the restriction enzyme recognition site used and the fragments obtained. Printed by the Consumer Cooperative of Intellectual Property Bureau of the Ministry of Economic Affairs. The length of the fragment obtained when any gene sequence obtained by the database is cut with a specific restriction enzyme, and the identification site of the restriction enzyme can be easily determined on the computer display. On the other hand, in fact, the length of a fragment obtained by restriction enzyme cleaving used in this method can be elucidated by performing electrophoresis. Therefore, if the adaptor sequence used is considered, the gene from which the fragment is derived can be identified without experimental analysis. An example of a theoretical identification method using a computer is described in Example 1 described later. The computer that can be used here may be a computer that is generally used. For example, a device including an input unit such as a keyboard and a mouse, an output unit such as a printer and a display, and an arithmetic unit such as a CPU can be used. In addition, examples of databases that can be obtained include GenBank, and this paper size applies the Chinese National Standard (cns) A4 specification (21 ox297 mm) ~ '-21-1237663 A7 B7 V. Description of the invention (19) EMB L and DDBI, etc. The data of other DataBanks, such as the public DataBank and commercial databases, is not limited to this. (Please read the notes on the back before filling out this page.) You can also combine experimental and theoretical methods. (4) Analysis of gene expression frequency In the method for generating a gene expression analysis chart according to the aspect of the present invention, the gene expression amount expressed by the test cell reflects the size of each peak shown in the chart. Therefore, by observing the change in the peak size, the expression frequency of the gene can be analyzed. For example, a comparison between normal cells and abnormal cells, a comparison between normal cells and cancer cells, a comparison between different cells, and a comparison between cells treated under different conditions can be performed. In addition, if a gene expressed or changed in a specific stimulus is identified according to this method in advance, a part of the gene expression analysis map can be created in subsequent experiments using only primers related to the specific gene. In this way, the expression frequency of the target gene can be analyzed. Printed in Example 1 by the Consumers ’Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs. The effects of radiation on P 2 1, mdm 2 and Cyc 1 in G performance are as follows. Review the radiation on P 2 1, mdm 2 and cyclin G performance. Influence. The mR N A obtained after irradiation of the rat breast cancer cell line S R-1 with radiation and the m R N A obtained from the unirradiated cells were used to make a gene expression analysis map and compared. This paper scale applies Chinese National Standard (CNS) A4 specification (21〇'297 mm) -22-1237663 A7 B7 V. Description of the invention (20) 1 · Genetic analysis map production Actual production According to the aspect of the present invention Analysis of gene expression. Koichi-1 mRNA extraction and cDNA synthesis Murine breast cancer cell line S R-1 (derived by Dr. Oyama, Yokohama City) was cultured in an αMEM culture medium in a 7 cm 3 flask (Falcon). This cell was irradiated with radiation from the upper side using 7 G y of P A N T A C Gai Jin Co., Ltd. The irradiation time was 3 hours. In addition, unirradiated cells were prepared in parallel as a control group. From each cell, 20 micrograms of total mRNA was extracted using Fast Track 2.0 Kit (Invitrogen). 20 micrograms of the extracted mRNA was mixed with 0.8 microliters of 5′-biotinylated dT primer (BRL) of 100 pmole and incubated at 65 ° C for 5 minutes. After ice-cooling, it was cultured in 20.0 microliters of reverse transcription buffer with a final concentration of 5 mM MgCl2 and 0.5 mM dNTP mixture (BRL) and 10 mM DTT (BRL) in culture 60. minute. Then 'put it in 150 μl of double-stranded synthetic buffer, with a final concentration of dNTP mixture (BRL) of 0. 27 mM and DTT (BRL) of 1.33 mM and 20.0 units E. coli ligase (BRL), 40.0 units of E. Coli DNA polymerase (Brl), and 2.0 units of RNaseH (BRL) were incubated at 16 ° C for 120 minutes, and thereafter at 7 ° C. Incubate for 15 minutes to stop the reaction. Use the paper size obtained by applying the Chinese National Standard (CNS) A4 (21〇 '乂 297 mm) (Please read the precautions on the back before filling this page).

、1T 經濟部智慧財產局員工消費合作社印製 1237663 A7 B7 五、發明説明(21 ) 反應產物予以二等分,視爲反應產物混合物A和反應產物 混合物B。 1 一 2 *反應產物混合物A之處理 如下述處理反應產物混合物A。此處,使用M s p I 做爲第一限制酶、M s e I做爲第二限制酶。 首先,於1 0 0微升中令最終濃度2 0單位之限制酶 M s p I ( Takara )、和1〇微克含有mRNA之反 應產物混合物A,於3 7 °C反應3 6 0分鐘。反應後,使 用乙醇予以精製(500微升x3回)。其次,將其於 1 5微升之T4 DNA連接酶緩衝液中,使用具有GC 序列(即,限制酶M s p I之切片斷斷部位之互補性序列 )之5 . 0微克的X適應子(B R L公司)、和1 〇單位 之Τ4 DNA連接酶(ΝΕΒ公司)進行連接。其後, 於此反應液中,添加固定有鏈霉抗生物素蛋白(Dinal 公司)的磁珠粒。對於被固定之鏈霉抗生物素蛋白,令反 應液中之雙股所含有之生物素予以結合,取得連接產物。 其後,將其於2 0 0微升中,與最終濃度5 0單位之 限制酶Ms el (NEB公司)於37 °C反應360分鏤 。將其上淸液移至另一管中,以乙醇精製(1 000微升 x3回)。其後,將其於10微升之T4 DNA連接酶 緩衝液中,與具有A T序列(即,限制酶M s e I之切片 斷斷部位的互補性序列)之1 〇 pmole Y適應子 (B R L公司),使用1 〇單位之T 4 D N A連接酶( 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閲讀背面之注意事項I填寫本ΐο tr 經濟部智慧財產局員工消費合作社印製 -24- 1237663 Μ __Β7__ 五、發明説明(d N E B )進行連接。 (請先閱讀背面之注意事項再填寫本頁) 其次,對於所得之連接產物進行P C R。此處,於χ 適應子具有互補性序列之X適應子5 ’側,結合三種螢光 色素FAM、NED及NED之任一種。更且,X適應子 爲於3 ’側具有任意的二鹼基N N。另一方面,於Y適應 子具有互補性序列之Y適應子爲於3 ’側具有任意的二鹼 基NN。各NN與螢光色素之組合爲如圖4所示。圖4中 將標幟所用之各物質,即,以F A Μ所標幟之序列於a欄 中記載,相同地Η E X於b欄中記載,N E D於c欄中記 載,且以(X引子之NN) — (Y引子之NN)型式記載 任意之二鹼基序列。此處,雖使用三種螢光探針,但其爲 用以提高作業效率。因此,即使使用一種螢光探針亦可同 樣實施。 經濟部智慧財產局員工消費合作社印製 具體而言,連接終了後,將此反應液使用 Tris-HCl 緩衝液(以下,簡稱爲T E )稀釋成6 1 2微升。對此稀 釋反應液1微升,將圖4所示F AM和HEX和NED各 個欄中所具備之第一序列,即,混合含有a ) F A Μ爲「 ΑΑ — ΑΑ」、b) HEX 爲「CT — ΑΑ」及 c) NED爲「CA — AA」引子之各1微升溶液添加混合。 同樣地,將各個位置記載序列之引子以三個1組混合者與 該稀釋反應液1微升混合。a) FAM之第8 1至第9 6 爲止因不存在Η E X和N E D,故單獨與該稀釋反應液1 微升混合。將依據上述操作由2 5 6種引子組所產生之 P C R反應產物作爲9 6個電泳用樣品。 本^張尺度適用中國國家標準(〇奶)八4規格(210父297公釐) 一 -25- 1237663 A7 B7 五、發明説明(Z3) i --------»衣! (請先閲讀背面之注意事項再填寫本頁} 對於此9 6個電泳用樣品進行電泳。電泳爲使用毛糸田 管定序機(ABI PRISM 3100、APpiied Bio systems Japan公司),於泳動電壓1 5 k V及泳動 時間2 0 0 0秒之條件下進行。電泳結果於橫軸取得以移 動距離做爲指標之分子量、縱軸取得以螢光強度做爲指丰票 之表示表現量之圖表。一個樣品中雖包含三種螢光物質所 標幟之P c R產物,但可根據改變波長而將其辨別。 1 - 3 反應產物混合物B之處理 除了使用M s e I做爲第一限制酶、M s p I做爲第 二限制酶以外,與上述反應產物混合物Α同樣地處理反應 產物混合物B。又,與反應產物混合物A同樣地,對9 6 個樣品進行電泳則取得圖表。 經由上述1 - 1和1 - 2同樣之方法,以電泳結果圖 表型式取得基因表現解析圖。 1 - 4 基因數據庫之解析 經濟部智慧財產局員工消費合作社印製 對於所得之基因表現解析圖中所檢測到的波峰,使用 數據庫的數據,鑑定其中所含的基因,取得關於所使用的 限制酶切斷部位、和經由切斷所得片斷之資料。 首先,將 GenBank之數據庫闡明mRNA全長之基 因、與僅註冊一部分序列之E S T所得的全部數據予以集 結,並且將每種來自各基因之數據整理成一個。由集結的 數據求出共通序列。共通序列與構成共通序列所用之一部 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -26- 1237663 A7 B7 五、發明説明(y 分序列示於圖7 (圖7 )。最上方所示之序列爲共通序列 。此處所使用之「共通序列」爲指關於一種基因之相同部 位,於鑑定複數序列之全部序列中,經由決定高或然率共 通序列所得之共通序列。圖6爲示出人類芳基胺N -乙醯 轉移酶之基因序列的一部分。 其次,對於此共通序列、和構成共通序列所用之全部 數據,檢測出最靠近3 ’側之限制酶X的辨識序列。其次 ,檢測出限制酶X之辨識部位開始於3 ’方向最近的限制 酶Y的辨識序列。M s p I之辨識序列爲C / C G G,於 「/」之位置切斷。又,M s e I之辨識序列爲 T / T A A。更且,由如此處理所得之限制酶X及Y之切 片斷斷,理論上算出所得D NA的鹼基數。如上述處理所 得數據之一例示於圖8 (圖8 )。 圖8中可知,由 GenBank之數據庫之數據和E S 丁 之許多的註冊數據,取得1 0 4 b p之切片斷斷(參照圖 8之「長度」欄。但是,又,由該數據亦提示於數個數據 中有變異或序列之讀取差異,亦有取得2 3 b p切片斷斷 的可能性(參照圖8之「長度」欄)。 其次,由該基因數據庫中,對於得知放射線照射增加 表現之基因、p 2 1 、mdm2 、 cyclin G 及 gadd 4 5,調查其切片斷斷長度、和限制酶辨識部位內側之二 鹼基序列。 1 — 5 基因之鑑定 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X297公釐) (請先閲讀背面之注意事項再填寫本頁) •訂 經濟部智慧財產局員工消費合作杜印製 -27- 1237663 A7 _____B7 五、發明説明(25) (請先閲讀背面之注意事項再填寫本頁) 經由比較檢討上述1 一 2及1 一 3所得之數據,和1 - 4所得之數據’則可進行本發明基因表現解析圖所檢測 之波峰中所含之基因的鑑定。 以數據庫所得之p 2 1 、m d m 2 、cyclin G及 g a d d 4 5之切片斷斷長度、和限制酶辨識部位內側之二 鹼基序列爲基礎,則可判知本方法所使用之5 1 2種引子 中,由何種引子組,即,X引子和Y引子之組合,檢測出 P 2 1、m d m 2、cyclin G 及 gadd 4 5。 又,同樣闡明所檢測出的D N A長度。以此爲基礎, 由電泳所分類之分子中,分取相當於對應分子量之波峰。 對於所分取之波峰中所含之D N A,經由定序列調查鹼基 序列’確s忍目的基因’ fiP ’ p 2 1 、m d m 2 、c y c 1 i η G 及 gadd 4 5 0Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs of the Ministry of Economic Affairs of the People's Republic of China. 1237663 A7 B7 V. Description of the invention (21) The reaction product is divided into two equal parts and treated as reaction product mixture A and reaction product mixture B. 1 to 2 * Treatment of reaction product mixture A The reaction product mixture A is treated as follows. Here, M s p I is used as the first restriction enzyme, and M s e I is used as the second restriction enzyme. First, in 100 microliters, a final concentration of 20 units of the restriction enzyme M s p I (Takara) and 10 micrograms of the reaction product mixture A containing mRNA were reacted at 37 ° C for 360 minutes. After the reaction, it was refined with ethanol (500 µl x 3 times). Next, it was used in 15 microliters of T4 DNA ligase buffer using 5.0 micrograms of the X aptamer (BRL) with the GC sequence (that is, the complementary sequence of the fragment break site of the restriction enzyme M sp I). Company), and 10 units of T4 DNA ligase (NEB). Thereafter, magnetic beads with immobilized streptavidin (Dinal) were added to the reaction solution. For the immobilized streptavidin, the biotin contained in the double strands in the reaction solution is combined to obtain a linked product. Thereafter, it was reacted in 200 μl with a restriction enzyme Ms el (NEB) at a final concentration of 50 units at 37 ° C for 360 minutes. Transfer the supernatant to another tube and refine with ethanol (1,000 μl x 3 times). Thereafter, it was incorporated in 10 μl of T4 DNA ligase buffer with a 10 pmole Y aptamer having the AT sequence (that is, the complementary sequence of the fragment break site of the restriction enzyme M se I) (BRL) Use 10 units of T 4 DNA ligase (This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) (Please read the precautions on the back first and fill out this ΐ tr Printed-24- 1237663 Μ __Β7__ V. Description of invention (d NEB) for ligation. (Please read the notes on the back before filling this page) Second, perform PCR on the resulting ligation product. Here, the χ aptamer has The 5 'side of the X adaptor of the complementary sequence combines any of the three fluorochromes FAM, NED, and NED. Furthermore, the X adaptor has an arbitrary two-base NN at the 3' side. On the other hand, it is at Y The Y aptamer with complementary sequences of the aptamer is an arbitrary two-base NN on the 3 'side. The combination of each NN and the fluorescent pigment is shown in Figure 4. In Figure 4, the substances used in the flag are , With the sequence marked by FA Μ at Column a is the same, EX is described in column b, NED is described in column c, and any two base sequence is described in the form (NN of X primers)-(NN of Y primers). Here, although Three fluorescent probes are used, but they are used to improve work efficiency. Therefore, even a single fluorescent probe can be used for the same purpose. Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs. The reaction solution was diluted to 6 1 2 microliters using Tris-HCl buffer (hereinafter referred to as TE). For this purpose, 1 microliter of the diluted reaction solution was used. One sequence, that is, mixing 1 microliters of each solution containing a) FA MH "AA-AA", b) HEX "CT-AA" and c) NED "CA-AA" primers. Similarly, the primers of the sequence described in each position were mixed with 1 microliter of the diluted reaction solution in three groups. a) Since there is no Η E X and N E D up to the 8th to the 9th of the FAM, they are separately mixed with 1 microliter of the diluted reaction solution. The P C R reaction products produced by the 256 primer sets according to the above operation were used as 96 samples for electrophoresis. This standard is applicable to the Chinese National Standard (〇 奶) 8.4 (210 father 297 mm) 1 -25-1237663 A7 B7 V. Description of the invention (Z3) i -------- »clothing! (Please read the precautions on the back before filling out this page} Electrophoresis was performed on these 9 6 samples for electrophoresis. The electrophoresis was performed using a Maotian tube sequencer (ABI PRISM 3100, APpiied Bio systems Japan), and the swimming voltage was 1 5 Performed under the conditions of k V and swimming time of 2000 seconds. The electrophoresis results are obtained on the horizontal axis with a molecular weight using a moving distance as an index, and on the vertical axis with a fluorescence intensity as a graph indicating a lot of money. Although the sample contains P c R products marked by three fluorescent substances, they can be discriminated by changing the wavelength. 1-3 The reaction product mixture B is processed except that M se I is used as the first restriction enzyme and M sp Except for I as the second restriction enzyme, the reaction product mixture B was treated in the same manner as in the reaction product mixture A. In addition, in the same manner as the reaction product mixture A, 9 6 samples were subjected to electrophoresis to obtain a graph. 1-2 In the same way, use the electrophoresis result chart to obtain the gene expression analysis chart. 1-4 Analysis of the gene database. Use the data in the database to identify the genes contained in the peaks detected in the analysis chart, and obtain information about the restriction enzyme cut-off site used and the fragments obtained through the cut-off. First, the mRNA of the GenBank database is clarified. The full-length genes and all the data obtained from the EST registered only a part of the sequences are aggregated, and each type of data from each gene is organized into one. The common sequence is obtained from the aggregated data. The common sequence and a part used to constitute the common sequence This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) -26- 1237663 A7 B7 V. Description of the invention (The y-sequence is shown in Figure 7 (Figure 7). The sequence shown at the top is a common sequence. The "common sequence" as used herein refers to a common sequence of the same part of a gene, which is obtained by determining a high-probability common sequence among all sequences identifying a plurality of sequences. Figure 6 shows the human arylamine N-acetamidine Part of the gene sequence of the transferase. Secondly, for this common sequence and all the data used to form the common sequence, The recognition sequence of restriction enzyme X closest to the 3 'side was detected. Second, the recognition site of restriction enzyme X was detected starting from the recognition sequence of restriction enzyme Y closest to the 3' direction. The recognition sequence of M sp I was C / CGG, It was cut at the position "/". Furthermore, the recognition sequence of M se I was T / TAA. Furthermore, the fragments of the restriction enzymes X and Y obtained in this way were cut, and the number of bases of D NA was theoretically calculated. An example of the data obtained as described above is shown in Figure 8 (Figure 8). It can be seen from Figure 8 that the 104 bp slice break is obtained from the data of the GenBank database and many of the ES registration data (refer to Figure 8 " Length "column. However, it is also suggested from this data that there are mutations or sequence read differences in several data, and it is also possible to obtain 2 3 b p slice breaks (refer to the "length" column in Fig. 8). Next, from this gene database, the genes that showed increased radiation exposure, p 2 1, mdm2, cyclin G, and gadd 4 5 were investigated for their cut lengths and the two base sequences inside the restriction enzyme recognition site. 1 — 5 Identification of genes This paper applies Chinese National Standard (CNS) A4 specifications (210 X297 mm) (please read the notes on the back before filling out this page) -27- 1237663 A7 _____B7 V. Description of the invention (25) (Please read the notes on the back before filling out this page) After a comparative review, review the data obtained from the above 1-2 and 1-13, and the data obtained from 1-4. Identification of genes contained in the peaks detected by the gene expression analysis map of the present invention can be performed. Based on the cut length of p 2 1, mdm 2, cyclin G, and gadd 4 5 obtained from the database and the two base sequences inside the restriction enzyme recognition site, the 5 1 2 primers used in this method can be determined In which primer set, that is, the combination of X and Y primers, detected P 2 1, mdm 2, cyclin G, and gadd 4 5. The detected D N A length is also explained. Based on this, among the molecules classified by electrophoresis, peaks corresponding to the corresponding molecular weights are fractionated. Regarding the D N A contained in the divided peaks, the base sequence is determined through the sequence determination. The gene ‘fiP’ p 2 1, m d m 2, c y c 1 i η G, and gadd 4 5 0

1—6 放射線照射對於P 2 1 、m d m 2、c y c 1 i n G 及 gadd 4 5表現量之影響。 經濟部智慧財產局員工消費合作社印製 根據上述方法所得之P 2 1、m d m 2及 cyclin G 之各個基因的波峰示於圖9、1 0及1 1。各圖上段之圖 表爲來自未照射放射線細胞所得之m R N A之基因表現解 析圖之一部分。下段圖表爲來自3小時之7 G y被照射細 胞所得之m R N A之基因表現解析圖之一部分。以箭頭表 示目的基因之波峰。 如圖9至1 1所示般,可確認經由照射放射線,則可 令P 2 1、m d m及 c y c 1 i n G各別表現量增加。又,雖 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) -28- 1237663 A7 B7 五、發明説明(26) 然未示出數據,但gadd 4 5亦取得同樣之結果。 實施例2 (請先閱讀背面之注意事項再填寫本頁} 基因表現頻率解析 更且,進行基因表現頻率解析。細胞爲使用分裂酵母 (以下,以S · p .表示)和出芽酵母(以下,以s . c ·表示)。與實施例1同樣萃取,並將所得總m r n A 之混合比、S . p .之mRNA量以〇、〇 . 〇2、 〇 · 2、1、2 及 2 微克、S · c •之mRNA 量以 2、 2、2 ' 2、2及Ο,如圖1 2所示般分別混合。 對於如上述調製之六種m R Ν Α調製物,如實施例工 所記載般製作基因表現解析圖。 所得基因表現解析圖之一部分圖表示於圖1 3。各圖 表之來自m R N A調製物之組成爲分別示於左側。最上段 之圖表爲示出S · p ·基因表現解析圖之一部分,且最下 段之圖表爲示出S _ c ·基因表現解析圖之一部分。 經濟部智慧財產局員工消費合作社印製 圖14爲將圖13所示圖表中來自S·p·之波峰以 縱軸予以連結。如圖1 4所示般,波峰大小之變化爲依賴 於該m R N A調製物中所含之S · p .的m R N A量。 由實施例1及2可知,根據本發明方法製作基因表現 解析圖,且所得之基因表現解析圖中所示之基因表現量, 爲充分反映試料中所存在之m R N A量。因此,可根據本 發明方法,解析基因表現頻率。 根據本發明態樣之方法,則可簡便作成關於在廣範圍 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) -29- 1237663 A7 B7 五、發明説明(27) 表現之基因的基因表現解析圖。又,根據此類基因表現解 析圖,則可比先前方法識別更多的表現基因,即,可識別 幾乎全部經表現的基因。又,根本發明態樣之基因表現解 析圖可對一個一個基因,進行各基因之識別。又,更且, 因爲其爲反映基因的表現量,故亦可解析基因表現頻率。 特別,關於未知之基因’亦可與已知之基因同樣地解析其 表現頻率。 其他之優點及變更可由業者輕易地想出。因此,於此 廣泛的側翼中,並無法將本發明限定於此處所示之詳細的 說明及典型的態樣中。因此,在不超脫所附之申請專利範 圍及其均等物所明示之全盤發明之思想精神或範圍,可作 出各種變更。 (請先閲讀背面之注意事項再填寫本頁) 經濟部智慧財產局員工消費合作社印製 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) -30- 1237663 A7 B7 五、發明説明(2S) 序列表 <110〉 AISIN SEIKI KABUSHIKI KAISHA National Institute of Radiological Sciences MAZE INC. Masumi Abe Toshiyuki Sairo <12ϋ> Method for analysing of gene expressionThe effect of 1-6 radiation on the performance of P 2 1, m d m 2, c y c 1 i n G, and gadd 45. Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs, the peaks of the genes of P 2 1, m d m 2 and cyclin G obtained according to the above methods are shown in Figs. 9, 10 and 11. The graph in the upper section of each figure is part of an analysis map of m R N A gene expression obtained from unirradiated cells. The lower graph is a part of the analytic map of m R N A from 7 G y irradiated cells over 3 hours. The peaks of the gene of interest are indicated by arrows. As shown in FIGS. 9 to 11, it can be confirmed that the respective expressions of P 2 1, m d m, and c y c 1 i n G can be increased by irradiation of radiation. In addition, although this paper size applies the Chinese National Standard (CNS) A4 specification (210X 297 mm) -28-1237663 A7 B7 V. Description of the invention (26) Although data is not shown, gadd 4 5 also achieved the same result. Example 2 (Please read the notes on the back before filling in this page} The analysis of gene expression frequency and the analysis of gene expression frequency. Cells are divided using yeast (hereinafter, denoted by S · p.) And budding yeast (hereinafter, (Expressed as s.c ·). Extracted in the same manner as in Example 1, and the resulting mixture ratio of total mrn A and the amount of mRNA of S.p. were expressed as 0, 0.02, 0.2, 1, 2, and 2 micrograms. , S · c • The amount of mRNA is 2, 2, 2 '2, 2 and 0, respectively, as shown in Figure 12. For the six m R Ν Α modulators prepared as described above, as in Example Works Gene expression analysis diagrams were prepared as described. Part of the obtained gene expression analysis diagrams are shown in Figure 13. The composition of the mRNA modulators from each diagram is shown on the left. The uppermost diagram shows S · p · genes. A part of the performance analysis chart, and the chart at the bottom is a part of the analysis chart of S _ c · gene performance. Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs. Figure 14 is from S · p · The wave crests are connected by the vertical axis. As shown in Figure 14, the wave The change in the peak size is dependent on the amount of m RNA contained in the m RNA modulator in the m RNA modulator. As can be seen from Examples 1 and 2, a gene expression analysis map was prepared according to the method of the present invention, and the obtained gene expression analysis map was obtained. The gene expression amount shown in the figure fully reflects the amount of m RNA present in the sample. Therefore, the gene expression frequency can be analyzed according to the method of the present invention. According to the method of the present invention, it can be easily made about The paper scale applies the Chinese National Standard (CNS) A4 specification (210X 297 mm) -29- 1237663 A7 B7 V. Description of the invention (27) An analysis map of the gene expression of the expressed genes. In addition, according to the analysis map of such gene expression, then More expression genes can be identified than the previous method, that is, almost all expressed genes can be identified. Moreover, the gene expression analysis map of the fundamental invention aspect can identify each gene for each gene. Furthermore, because, This is to reflect the expression level of a gene, so it is also possible to analyze the expression frequency of a gene. In particular, for unknown genes, the expression frequency can also be analyzed in the same way as a known gene. . Other advantages and changes can be easily conceived by the industry. Therefore, in this broad flanking, the present invention cannot be limited to the detailed description and typical aspects shown here. Therefore, it is not beyond the scope of it. The attached scope of the patent application and the ideological spirit or scope of the overall invention explicitly expressed by the equivalent can be changed in various ways. (Please read the notes on the back before filling out this page.) This paper is printed by the Consumers ’Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs Standards apply to Chinese National Standard (CNS) A4 specifications (210 X 297 mm) -30- 1237663 A7 B7 V. Description of invention (2S) Sequence Listing < 110〉 AISIN SEIKI KABUSHIKI KAISHA National Institute of Radiological Sciences MAZE INC. Masumi Abe Toshiyuki Sairo < 12ϋ > Method for analysing of gene expression

<130> 01S1459P <150> JP 2000-377887 <151〉 2000-12-12 „ . 衣-- (請先閲讀背面之注意事項再填寫本頁) 訂 經濟部智慧財產局員工消費合作社印製 <160〉 24 <170〉 Paieniln version 3. 1 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -31 - 1237663 A7 B7 五、發明説明(29) (請先閱讀背面之注意事項再填寫本頁) <210> 1 (211) 22 <212> DNA <213〉 人工 <400> 1 ! cgggicgxax cagactigca ca 22 經濟部智慧財產局員工消費合作社印製 <210〉 2 <211> 20 <212〉隨 <213> <400> 2 igigcaagtc tgatacgacc 20 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) -32- 1237663 A7 B7 五、發明説明(30) <210> 3 <211> 22< 130 > 01S1459P < 150 > JP 2000-377887 < 151〉 2000-12-12 „. Clothes-(Please read the notes on the back before filling out this page) Order the stamp of the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs ≪ 160〉 24 < 170〉 Paieniln version 3. 1 This paper size applies to China National Standard (CNS) A4 (210X297 mm) -31-1237663 A7 B7 V. Description of Invention (29) (Please read the back first Please fill out this page again) < 210 > 1 (211) 22 < 212 > DNA < 213〉 Artificial < 400 > 1! Cgggicgxax cagactigca ca 22 Printed by the Consumers ’Cooperative of Intellectual Property Bureau of the Ministry of Economic Affairs < 210 〉 2 < 211 > 20 < 212〉 With < 213 > < 400 > 2 igigcaagtc tgatacgacc 20 This paper size applies the Chinese National Standard (CNS) A4 specification (210X 297 mm) -32- 1237663 A7 B7 V. Description of the invention (30) < 210 > 3 < 211 > 22

<212> DNA <213> 人工 丨 <400〉 3 ! I tacatcaggx gtccgatgat re 22 <21ϋ> 4 <211) 20 <212〉 DNA <213〉 人工 <400) 4 gaatcatcgg acacctgaig <210〉 5 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) ·裝· 訂 經濟部智慧財產局員工消費合作社印製 -33- 1237663 A7 B7 五、發明説明(31) 丨 衣-- (請先閱讀背面之注意事項再填寫本頁) <211> 22 <212> DNA (213〉 人工 <400> 5 cgagtcgtat cagacttgca ca 22 I <210> 6 I <211> 20 <212> DNA <213〉 人工 經濟部智慧財產局員工消費合作社印製 <400> 6 igigcaagic igaxacgaci:· 2〇 <210> 7 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) -34- 經濟部智慧財產局員工消費合作社印製 1237663 A7 B7 五、發明説明(32) <211> 22 <212> DNA j <213> 人工 <400〉 7 xacttggact acagtcgtga ca 22 <210〉 8 〈211〉 20 <212> DNA <213〉人工 . <400〉 8 tgtcacgacx gtagiccaag 20 <210> 9 <211> 116 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 1.---*--------:---、訂------« (請先閲讀背面之注意事項再填寫本頁) -35- 1237663 A7 ____ B7五、發明説明(33) <212^ DNA <213> Homo sapiens 經濟部智慧財產局員工消費合作社印製 <400> 9 gaaaccgggg tgggtggtgt ciccaggica atcaacttct gtacigggct ctgaccacaa 60 icggxtttca gaccacaaxg naggagggt atttttacat cccxccag-ττ aacaaa 116 (210> 10 <211> 116 <212> DNA <213> Homo sapiens <400> 10 gaaaccgggg tgggtggtgt ctccaggtca aicaactict giactgggcx ctgaccacaa 60 tcggttttca gaccacaarg ttaggagggt atniiacai cccxccagxi aacaaa 116 IK---.------ (請先閲讀背面之注意事項再填寫本頁) 訂 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -36- 1237663 A7 B7 五、發明説明(34) <210> 11 <211> 116< 212 > DNA < 213 > artificial 丨 < 400〉 3! I tacatcaggx gtccgatgat re 22 < 21ϋ > 4 < 211) 20 < 212〉 DNA < 213〉 artificial < 400) 4 gaatcatcgg acacctgaig < 210〉 5 This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) (Please read the precautions on the back before filling this page) · Binding · Order printed by the Intellectual Property Bureau of the Ministry of Economic Affairs Consumer Cooperatives -33 -1237663 A7 B7 V. Description of the invention (31) 丨 Clothing-(Please read the precautions on the back before filling out this page) < 211 > 22 < 212 > DNA (213> Artificial &400; 5cgagtcgtat cagacttgca ca 22 I < 210 > 6 I < 211 > 20 < 212 > DNA < 213〉 Printed by the Consumer Cooperative of Intellectual Property Bureau of the Ministry of Artificial Economy < 400 > 6 igigcaagic igaxacgaci: · 2〇 < 210 > 7 copies Paper size applies Chinese National Standard (CNS) A4 (210X 297 mm) -34- Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs 1237663 A7 B7 V. Description of the invention (32) < 211 > 22 < 212 > DNA j < 213 > artificial &400; 7 xacttggact acagtcgtga ca 22 < 210〉 8 〈211〉 20 < 212 > DNA < 213〉 artificial. < 400〉 8 tgtcacgacx gtagiccaag 20 < 210 > 9 < 211 > 116 This paper is in accordance with the Chinese National Standard (CNS) ) A4 specification (210X 297mm) 1 .--- * --------: ---, order ------ «(Please read the notes on the back before filling this page)- 35- 1237663 A7 ____ B7 V. Explanation of the invention (33) < 212 ^ DNA < 213 > Homo sapiens Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs < 400 > 9 gaaaccgggg tgggtggtgt ciccaggica atcaacttct gtacigggct ctgaccacaa 60 gagaggxtx gagggxt cccxccag-ττ aacaaa 116 (210 > 10 < 211 > 116 < 212 > DNA < 213 > Homo sapiens < 400 > 10 gaaaccgggg tgggtggtgt ctccaggtca aicaactict giactgggcx ctgaccacaa 60 tcggtttag iac-txggagxi tacggargia ----- (Please read the precautions on the back before filling this page) The size of the paper used in this edition applies to Chinese National Standard (CNS) A4 (210X297 mm) -36- 1237663 A7 B7 V. Description of the invention 34) < 210 > 11 < 211 > 116

<212> DNA <213> Homo sapiens <400> 11 gaaaccgggg rgggxggigx ciccaggxca atcaactrct gtactgg^ct cigaccacaa i tcggttttca gaccacaatg tiaggagggi attixxacai ccciccagxx aacaaa 60 I- I - 一 - - i _ - ..... - - - I (請先閲讀背面之注意事項再填寫本頁) 訂 <210> 12 <211> 116< 212 > DNA < 213 > Homo sapiens < 400 > 11 gaaaccgggg rgggxggigx ciccaggxca atcaactrct gtactgg ^ ct cigaccacaa i tcggttttca gaccacaatg tiaggagggi attixxacai ccciccag----aacaaa-60- I (Please read the notes on the back before filling this page) Order < 210 > 12 < 211 > 116

&lt;212&gt; DNA 經濟部智慧財產局員工消費合作社印製 &lt;213&gt; Homo sapiens &lt;400〉 12 gaaaccgggg tgggxggtgt ctccaggtca atcaacttct gtactgggct ctgaccacaa 60 本紙張尺度適用中國國家標準() A4規格(2l〇x297公釐) 37- 1237663 A7 B7 五、發明説明(35) tcggmtca gaccacaatg txaggagggx atttttacai ccctccagti aacaaa 116 &lt;210&gt; 13 &lt;211&gt; 116 &lt;212〉 DNA &lt;213&gt; Homo sapiens &lt;400〉 13 gaaaccgggg igggiggtgi ciccaggtca atcaacxxct gtacigggct ctgaccacaa 60 i I icggxixtca gaccacaatg itaggagggt atttttacai ccctccagti aacaaa 116 &lt;210&gt; 14 &lt;211&gt; 116 〈212〉 DNA &lt;213&gt; Homo sapiens 本紙張尺度適用中國國家標準(CNS ) A4規格(21 297公釐) I----.----衣-- (請先閱讀背面之注意事項再填寫本頁)&lt; 212 &gt; Printed by the Consumer Cooperatives of Intellectual Property Bureau of the Ministry of Economic Affairs &lt; 213 &gt; Homo sapiens &lt; 400〉 12 gaaaccgggg tgggxggtgt ctccaggtca atcaacttct gtactgggct ctgaccacaa 60 This paper is in accordance with the Chinese National Standard (A4) (2l0x297 mm) ) 37- 1237663 A7 B7 V. Description of the invention (35) tcggmtca gaccacaatg txaggagggx atttttacai ccctccagti aacaaa 116 &lt; 210 &gt; 13 &lt; 211 &gt; 116 &lt; 212〉 DNA &lt; 213 &gt; Homo sapiens &lt; 400> 13 ciaggtgtggatgggg gtacigggct ctgaccacaa 60 i I icggxixtca gaccacaatg itaggagggt atttttacai ccctccagti aacaaa 116 &lt; 210 &gt; 14 &lt; 211 &gt; 116 <212> DNA &lt; 213 &gt; Homo sapiens This paper is in accordance with the Chinese National Standard (CNS) 297 A4 standard I ----.---- Clothing-(Please read the precautions on the back before filling this page)

、1T 經濟部智慧財產局員工消費合作社印製 1237663 A7 B7 五、發明説明(泥) &lt;400&gt; 14 gaaaccgggg tgggtggtgi ctccaggrca aicaacttct giacigggct cxgaccacaa icggttitca gaccacaatg itaggagggt aimtacai ccutccagn aacaaa &lt;210〉 15 &lt;211〉 116 &lt;212&gt; DNA &lt;213&gt; Homo sapiensPrinted by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs of the Ministry of Economic Affairs of the People's Republic of China. 1237663 A7 B7 V. Description of the invention (mud) &lt; 400 &gt; 14 gaaaccgggg tgggtggtgi ctccaggrca aicaacttct giacigggct cxgaccacaa icggttitca gaccacaatg itaggagggt aimtacaiaca &lt; cgtcca &lt;116;; 212 &gt; DNA &lt; 213 &gt; Homo sapiens

I ! &lt;400〉 15 gaaaccgggg igggtggtgt ctccaggtca atcaacttct gxacigggci cxgaccacaaI! &Lt; 400〉 15 gaaaccgggg igggtggtgt ctccaggtca atcaacttct gxacigggci cxgaccacaa

I icggmica gaccacaatg itaggagggt aitmacai ccctccagit aacaaaI icggmica gaccacaatg itaggagggt aitmacai ccctccagit aacaaa

&lt;210&gt; 16 &lt;211&gt; 116 I &lt;212〉 DNA &lt;213&gt; Homo sapiens 本紙張尺度適用中國國家標準(CNS ) A4規格(21〇X 297公釐) (請先閱讀背面之注意事項再填寫本頁) 、r 經濟部智慧財產局員工消費合作社印製 -39- 1237663 A7 B7 五、發明説明(37) &lt;400&gt; 16 gaaaccgggg tgggtggigt ctccaggica axcaacnci gtactgggct ctgaccacaa 60 tcggxittca gaccacaatg ttaggagggx amitaxai ccctccagit aacaaa 116 &lt;210&gt; 17 &lt;211〉 116 &lt;212&gt; DNA &lt;213&gt; Homo sapiens i &lt;400&gt; 17 gaaaccgggg tgggiggtgx ciccaggxca atcaacitct gtactgggct ctgaccacaa 60 tcggitxxca gaccacaatg naggagggt azzzixazaz ccciccagtt aacaaa 116 &lt;210&gt; 18 &lt;211〉 116 I--------- (請先閱讀背面之注意事項再填寫本頁) -- Γ 經濟部智慧財產局員工消費合作社印製 本紙張尺度適用中國國家標準(CNS ) Α4規格(2丨〇&gt;&lt;297公釐) -40 - 1237663 A7 B7 五、發明説明(38)&lt; 210 &gt; 16 &lt; 211 &gt; 116 I &lt; 212〉 DNA &lt; 213 &gt; Homo sapiens This paper size applies the Chinese National Standard (CNS) A4 specification (21〇X 297 mm) (Please read the precautions on the back first Refill this page), r Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs-39- 1237663 A7 B7 V. Invention Description (37) &lt; 400 &gt; 16 gaaaccgggg tgggtggigt ctccaggica axcaacnci gtactgggct ctgaccacaa 60 tcggxittca gaccacaatg ttaggagcc 116 ; 210 &gt; 17 &lt; 211> 116 &lt; 212 &gt; DNA &lt; 213 &gt; Homo sapiens i &lt; 400 &gt; 17 gaaaccgggg tgggiggtgx ciccaggxca atcaacitct gtactgggct ctgaccacaa 60 tcggitxxca gaccacaatg nagazagtgt cc &gt; cc &gt; cc &gt; I --------- (Please read the notes on the back before filling this page)-Γ The paper printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs is compliant with China National Standards (CNS) Α4 specifications (2丨 〇 &gt; &lt; 297 mm) -40-1237663 A7 B7 V. Description of the invention (38)

&lt;212&gt; DNA &lt;213&gt; Homo sapiens &lt;400〉 18 , gaaaccgggg tgggiggtgt ctccaggtca atcaacttcx giacxgggci ctgaccacaa 60 icggttttca gaccacaatg itaggagggt aixxtiacat ccciccagzz aacaaa 116 &lt;210&gt; 19 &lt;211&gt; 116 I . i ! &lt;212&gt; DNA ·&lt; 212 &gt; DNA &lt; 213 &gt; Homo sapiens &lt; 400〉 18, gaaaccgggg tgggiggtgt ctccaggtca atcaacttcx giacxgggci ctgaccacaa 60 icggttttca gaccacaatg it & gagagtgt aixxtiacat cccicclt &gt; 116 &gt; 210 ·

I i &lt;213&gt; Homo sapiens &lt;400&gt; 19 gaaaccaggg tgggtggtgi ctccaggtca axcaacrccx gtacigggct ctgaccacaa 60 tcggititca gaccacaatg tiaggagggt aimiacat ccctccagtt aacaaa 116 &lt;210〉 20 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) 衣·I i &lt; 213 &gt; Homo sapiens &lt; 400 &gt; 19 gaaaccaggg tgggtggtgi ctccaggtca axcaacrccx gtacigggct ctgaccacaa 60 tcggititca gaccacaatg tiaggagggt aimiacat ccctccagtt aacaaa 116 standard (Standard 210) China 210 Standards (210) China 210 Standards 210 (Please read the precautions on the back before filling out this page)

、1T 經濟部智慧財產局員工消費合作社印製 -41 - 1237663 A7 B7 五、發明説明(39) &lt;211&gt; 116 &lt;212&gt; DNA &lt;213&gt; Homo sapiens &lt;400&gt; 20 gaaaccgggg rgggtggigi ctccaggtca aicaacttci gxactgggcx cigaccacaa 60 icggtxttca gaccacaatg ttaggagggt aittttacat ccctccagtt aacaaa 116 &lt;210&gt; 21Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs-41-1237663 A7 B7 V. Description of Invention (39) &lt; 211 &gt; 116 &lt; 212 &gt; DNA &lt; 213 &gt; Homo sapiens &lt; 400 &gt; 20 gaaaccgggg rgggtggigi ctccaggtca aicaacttci gxactgggcx cigaccacaa 60 icggtxttca gaccacaatg ttaggagggt aittttacat ccctccagtt aacaaa 116 &lt; 210 &gt; 21

I ! ' &lt;211〉 116 I . &lt;212&gt; DNA 〈213〉 Homo sapiens I &lt;400) 21 gaaaccgggg igggtggigi cxccaggxca atcaacxtci giacigggcx cxgaccacaa 60 tcggttttca gaccacaatg ttaggagggt atttttaiai ccctccagtt aacaaa 116 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) 訂 k9·. 經濟部智慧財產局員工消費合作社印製 -42- 1237663 A7 B7 五、發明説明(4〇) &lt;210&gt; 22 &lt;211&gt; 116 〈212〉 DNA &lt;213&gt; Homo sapiens (請先閲讀背面之注意事項再填寫本頁) &lt;400&gt; 22 gaaaccgggg tgggiggigi ctccaggtca aicaacxtct gtacigggct ctgaccacaa 60 ! ^cggrmca gaccacaatg naggagggt atttttacat ccctccagtt aacaaa 116 ! &lt;210&gt; 23 &lt;211&gt; 116 &lt;212&gt; DNA &lt;213&gt; Homo sapiens &lt;400&gt; 23 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 訂 # 經濟部智慧財產局員工消費合作社印製 43 1237663 A7 B7 五、發明説明(41) gaaaccgggg tgggtggigi ctccaggtca atcaacrtci gtacxgggct ctgaccacaa 60 tcggttttca gaccacaatg ttaggagggi aimiacax ccctccagtt aacaaa 116 &lt;210) 24 &lt;211〉 116 &lt;212&gt; DNA &lt;213&gt; Homo sapiens &lt;400, 24 I gaaaccaggg tgggiggtgi ctccaggtca atcaacttci giactgggci ctgaccacaa 60 tcggtitica gaccacaatg ttagga^ggt atttxiaiat cccxccagri aacaaa 116 (請先閱讀背面之注意事項再填寫本頁) _裝· 訂 經濟部智慧財產局員工消費合作社印製 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -44-I! '&Lt; 211> 116 I. &Lt; 212 &gt; DNA 〈213〉 Homo sapiens I &lt; 400) 21 gaaaccgggg igggtggigi cxccaggxca atcaacxtci giacigggcx cxgaccacaa 60 tcggttttca gaccacaatg ttaggagggt atttttaiacc cc standard A4 specifications (210X 297 mm) (Please read the notes on the back before filling out this page) Order k9 ·. Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs-42- 1237663 A7 B7 V. Description of Invention (4〇) &lt; 210 &gt; 22 &lt; 211 &gt; 116 <212> DNA &lt; 213 &gt; Homo sapiens (Please read the notes on the back before filling out this page) &lt; 400 &gt; 22 gaaaccgggg tgggiggigi ctccaggtca aicaacxtct gtacigggct ctgaccacaa 60! ^ Atggttgca gacc ccctccagtt aacaaa 116! &lt; 210 &gt; 23 &lt; 211 &gt; 116 &lt; 212 &gt; DNA &lt; 213 &gt; Homo sapiens &lt; 400 &gt; 23 This paper size applies the Chinese National Standard (CNS) A4 specification (210X 297 mm) Order # Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs 43 1237663 A7 B7 V. Description of Invention (41) gaaaccgggg t gggtggigi ctccaggtca atcaacrtci gtacxgggct ctgaccacaa 60 tcggttttca gaccacaatg ttaggagggi aimiacax ccctccagtt aacaaa 116 &lt; 210) 24 &lt; 211> 116 &lt; 212 &gt; DNA &lt; 213 &gt; Homo sapiens &lt; 400, 24 I gaaaccaggg tgggiggtgi ctccaggtca atcaacttci giactgggci ctgaccacaa 60 tcggtitica gaccacaatg ttagga ^ ggt atttxiaiat cccxccagri aacaaa 116 (Please read the notes on the back before filling out this page) _Packing and Ordering Printed by the Intellectual Property Bureau Staff Consumer Cooperatives of the Ministry of Economics This paper is printed in accordance with China National Standard (CNS) A4 (210X297 mm) -44-

Claims (1)

1237663 經濟部智慧財產局員工消費合作社印製 A8 B8 C8 D8 ^、_重諸專系i範圍 1 1 · 一種製作基因表現解析圖之方法,具備下述步驟 (a )對於由細胞所抽提之m R N A,合成於其3 ’ 終端上加成標的物質之c D N A之步驟, (b )將所得之反應產物以第一限制酶X予以切斷之 步驟, (c )將具有對第一限制酶X之限制酶切斷部位之序 列呈互補性序列的X適應子,對於步驟b所得之片斷進行 結合之步驟, (d )經由對該標的物質結合具有高親和性之物質, 則可回收步驟c所得片斷之步驟, (e )將步驟d所回收之片斷以第二限制酶Y予以切 斷,除去結合至該標的物質之片斷,則可取得含有經切斷 c D N A 5 ’側片斷之步驟, (f )對於步驟e所得之片斷,將具有對第二限制酶 Y辨識切斷部位之序列呈互補性序列之Y適應子予以加成 之步驟, (g )使用對該X適應子序列具有互補性序列且其 3 ’終端具有任意二個鹼基序列N N之引子,與對該Y適 應子序列具有互補性序列且其3 ’終端具有任意二個鹼基 序列N N之引子,並對於前述步驟f所得之片斷進行 P C R反應之步驟, (h )將所得之P C R產物進行電泳,經由檢測移動 距離和波峰,製作基因表現解析圖之步驟。 本紙張尺度適用中國國家標準(CNS ) A4規格(ΉΟΧ297公釐) (請先聞讀背面之注意事項再填寫本頁)1237663 Printed by A8, B8, C8, D8, Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs ^, _Zhongzhu Special Department i Scope 1 1 · A method for making analysis of gene expression, with the following steps (a) m RNA, a step of synthesizing c DNA to which a target substance is added at its 3 'terminal, (b) a step of cutting the obtained reaction product with a first restriction enzyme X, (c) having a first restriction enzyme The X adaptor in which the sequence of the restriction enzyme cutting site of X is a complementary sequence is a step of combining the fragments obtained in step b. (D) By binding a substance having a high affinity to the target substance, step c can be recovered. In the step of obtaining the fragment, (e) the fragment recovered in step d is cut with a second restriction enzyme Y, and the fragment bound to the target substance is removed, and then a step containing the cut 5 'side fragment of c DNA can be obtained, (f) For the fragment obtained in step e, a step of adding a Y aptamer having a complementary sequence to the sequence of the second restriction enzyme Y recognition cut site, and (g) using a complement to the X aptamer sequence Sex sequence And its primer at the 3 ′ terminal has an arbitrary two base sequence NN, and a primer complementary to the Y adaptor sequence and its primer at the 3 ′ terminal has an arbitrary two base sequence NN. The step of performing a PCR reaction on the fragment, (h) performing the electrophoresis of the obtained PCR product, and preparing the gene expression analysis map by detecting the moving distance and the wave peak. This paper size applies to Chinese National Standard (CNS) A4 specification (ΉΟ × 297mm) (Please read the precautions on the back before filling this page) -45 - 1237663 A8 B8 C8 D8 六、申請專利範圍 經濟部智慧財產局員工消費合作社印製 2 參 如 串 請 專 利 範 圍 第 方 法 5 其 中 對 該 X 適 應 子 序 3 5 終 端 具 有任 -Afe: 二 個 鹼 基 5 3 終 端 加 成 螢 光 物 質 藉 爲 經 由 檢 測 出 該 螢 光 物 質 之 3 • 如 串 請 專 利 範 圍 第 方 法 , 其 中 該 限 制 酶 X 及 該 群 中 分別 « 出 ; A C C I I A S P L Ε I B f a I Λ B S h 1 2 3 6 I B S h B s P 1 4 3 I 、 B S t U C f 〇 I C S P 6 I D Η a e I I I Η a P I I Η i n 6 I Λ Η i η P 1 I Η s P 9 2 I I Η S P A Μ b 〇 I Μ S e I Λ Μ s \ N 1 a I I I Λ Ρ a 1 I S s e 9 I Λ Τ a q I Ν T τ r u 9 I Τ s Ρ 5 0 9 τ t h Η Β 8 I o 4 • 如 串 請 專 利 範 圍 第 方 法 其 中 該 限 制 酶 X 爲 M Μ s e I 〇 5 • 如 串 請 專 利 範 圍 第 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 1項之製作基因表現解析圖之 列具有互補性序列且其 序列N N之引子,係再於其 此,該P C R產物之電泳結果 螢光量而進行。 1項之製作基因表現解析圖之 限制酶Y爲由下列所示之酵素 、AfaI、AluI、 B s c F I 、 I、B s i S I、 I、B s u R I、 pnII、FnuDII、 、HhaI、Hin2I、 、H p a I I 、 I 、Kz〇9I 、MaeI 、 pi 、MvnI 、NdeI I 、RsaI、Sau3AI、· hal、Trull 、 I、T s p E I 及 1項之製作基因表現解析圖之 s p I ,且該限制酶Y爲 1項之製作基因表現解析圖之 (請先閱讀背面之注意事項再填寫本頁) 、1T -46- 1237663 A8 B8 C8 D8 六、申請專利範圍 3 方法,其中該X適應子中所含之NN和Y適應子中所含之 N N爲將腺嘌呤、胸腺嘧啶、鳥嘌呤及胞嘧啶組合設計者 ,且全部使用2 5 6種之X及Y適應子。 6 .如申請專利範圍第1項之製作基因表現解析圖之 方法,其中該標的物質與對標的物質具有高親和性之物質 之組合係選自由生物素和鏈霉抗生物素蛋白、生物素和抗 生物素蛋白、F I TC和F I TC抗體、D I G和抗 D I G、蛋白質A和鼠I g G、及膠乳粒子所組成群。 7 .如申請專利範圍第1項之製作基因表現解析圖之 方法,其爲於經由將該P C R產物予以電泳,檢測出移動 距離和肅峰,製作基因表現解析圖之步驟後, 再具備將檢測出之波峰回收且藉由定序列決定出其所 含之P C R產物之序列,並且鑑定所表現基因之步驟。 8 ·如申請專利範圍第1項之製作基因表現解析圖之 方法,其爲再具備將該限制酶X及限制酶Y之辨識序列、 和步驟a所得之反應產物以限制酶X及限制酶Y切斷所得 之片斷長度、和任意數據庫所取得之數據,於電腦上進行 比較,鑑定出經表現基因之步驟。 9 . 一種製作基因表現解析圖之方法,具備下述步驟 (a )對於由細胞所萃取之m R N A,合成於其3 ’ 終端上加成標的物質之c D N A,並將所得之合成產物分 成二個餾分之步驟, (b )將所得之反應產物以第一限制酶X予以切斷之 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) 訂: 經濟部智慧財產局員工消費合作社印製 -47- 1237663 Α8 Β8 C8 D8 經濟部智慧財產局員工消費合作社印製 六、申請專利範圍 4 步驟, (c )將具有對第一限制酶X之限制酶切斷部位之序 列呈互補性序列的X適應子’對於步驟b所得之片斷進行 結合之步驟, (d )經由對該標的物質結合具有高親和性之物質, 則可回收步驟c所得片斷之步驟, (e )將步驟d所回收之片斷以第二限制酶Y予以切 斷,除去結合至該標的物質之片斷,則可取得含有經切斷 c D N A 5 ’側片斷之步驟, (f )對於步驟e所得之片斷’將具有對第二限制酶 Y辨識切斷部位之序列呈互補性序列之Y適應子予以加成 之步驟, (g )使用對該X適應子序列具有互補性序列且其3 ,終端具有任意二個鹼基序列NN之引子,與對該Y適應 子序列具有互補性序列且其3 ’終端具有任意二個鹼基序 列N N之引子,並對於前述步驟f所得之片斷進行P C R 反應之步驟, (h )將步驟a所得之第二合成產物餾分以該限制酶 Y予以切斷之步驟, (i )將具有對該限制酶Y之限制酶切斷部位之序列 呈互補性序列的Y ’適應子,對於步驟h所得之片斷進行 結合之步驟’ (j )經由對該標的物質結合具有高親和性之物質, 則可回收步驟i所得片斷之步驟, t紙張尺度適用中_國家標準(CNS ) A4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁)-45-1237663 A8 B8 C8 D8 VI. Application for Patent Scope Printed by the Consumers' Cooperative of Intellectual Property Bureau of the Ministry of Economic Affairs 2 Please refer to the Patent Scope Method 5 where the X adaptation subsequence 3 5 terminal has any -Afe: two The base 5 3 terminal addition fluorescent substance is detected by detecting 3 of the fluorescent substance. • If the method of patent scope is requested, the restriction enzyme X and the group are «out; ACCIIASPL EI IB fa I Λ BS h 1 2 3 6 IBS h B s P 1 4 3 I, BS t UC f 〇ICSP 6 ID Η ae III Η a PII Η in 6 I Λ Η i η P 1 I Η s P 9 2 II Η SPA Μ b 〇I Μ S e I Λ Μ s \ N 1 a III Λ Ρ a 1 IS se 9 I Λ Τ aq I Ν T τ ru 9 I Τ s ρ 5 0 9 τ th Η Β 8 I o 4 Method of patent scope, where the restriction enzyme X is M Μ se I 〇 5 • If you ask for the scope of the patent, the paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) 1 Gene expression analysis diagram of the production column having a complementary sequence and the sequence of the primers N N, and then based thereon Here, the electrophoresis fluorescence amount P C R of the product is carried out. The restriction enzyme Y for the analysis of gene expression in item 1 is the enzymes, AfaI, AluI, B sc FI, I, B si SI, I, B su RI, pnII, FnuDII,, HhaI, Hin2I,, H pa II, I, Kz〇9I, MaeI, pi, MvnI, NdeI I, RsaI, Sau3AI, hal, Trull, I, T sp EI and sp I of the gene expression analysis chart, and the restriction enzyme Y is 1 for the analysis of gene expression (please read the precautions on the back before filling this page), 1T -46-1237663 A8 B8 C8 D8 6. Method of applying for patent scope 3, in which the X adaptor contains The NN included in the NN and Y aptamers is a designer who combines adenine, thymine, guanine, and cytosine, and all 256 kinds of X and Y aptamers are used. 6. The method for making a gene expression analysis map according to item 1 of the scope of patent application, wherein the combination of the target substance and the substance with high affinity to the target substance is selected from the group consisting of biotin and streptavidin, biotin and A group of avidin, FI TC and FI TC antibodies, DIG and anti-DIG, protein A and murine Ig G, and latex particles. 7. The method for making a gene expression analysis chart according to item 1 of the scope of the patent application, which comprises the steps of preparing a gene expression analysis chart after detecting the moving distance and peak reduction by electrophoresis of the PCR product, The peaks recovered are the steps of determining the sequence of the PCR product contained in the sequence by determining the sequence, and identifying the expressed genes. 8 · The method for making a gene expression analysis map according to item 1 of the scope of patent application, which further comprises the identification sequence of the restriction enzyme X and the restriction enzyme Y, and the reaction product obtained in step a to restrict the enzyme X and the restriction enzyme Y. The length of the cut fragments and the data obtained from any database are compared on a computer to identify the expressed genes. 9. A method for making an analysis map of gene expression, comprising the following steps (a): synthesize m DNA extracted from a cell by adding c DNA to a 3 'terminal of the target substance, and divide the obtained synthetic product into two Steps for each fraction, (b) The paper size of the obtained reaction product is cut by the first restriction enzyme X. The paper size of this paper applies the Chinese National Standard (CNS) A4 specification (210X297 mm) (Please read the precautions on the back before filling in This page) Order: Printed by the Employees 'Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs-47- 1237663 Α8 Β8 C8 D8 Printed by the Employees' Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs 6. The scope of patent application 4 steps, (c) will have the first limit Step X of the restriction enzyme of enzyme X is a complementary sequence of the X adaptor to the fragment obtained in step b. (D) The step of recovering the target substance by binding to a substance with a high affinity can be recovered. (c) The fragment obtained in step (c) is cut with the second restriction enzyme Y to remove the fragment bound to the target substance, and then the A step of cutting the 5 'side fragment of c DNA, (f) a step of adding a Y aptamer complementary to the sequence of the second restriction enzyme Y recognition cut site for the fragment obtained in step e, (g ) Use a primer that has a complementary sequence to the X aptamer sequence and 3 and a terminal that has any two base sequences NN, and a primer that has a complementary sequence to the Y aptamer sequence and 3 'terminal that has any two bases A sequence of NN primers, and a step of performing a PCR reaction on the fragment obtained in the foregoing step f, (h) a step of cutting the second synthetic product fraction obtained in step a with the restriction enzyme Y, (i) having Restriction enzyme Y's adaptor at the restriction enzyme cutting site is a complementary sequence of the Y 'aptamer, the step of combining the fragments obtained in step h' (j) by binding a substance with a high affinity to the target substance, Step of recycling the fragments obtained in step i, t paper size is applicable _ National Standard (CNS) A4 size (210X297 mm) (Please read the precautions on the back before filling this page) -48- 1237663 A8 B8 C8 D8 申請專利範圍 5 經濟部智慧財產局員工消費合作社印製· (k )將步驟j所回收之片斷以限制酶X予以切斷’ 除去結合至該標的物質之片斷,則可取得含有經切斷 c D N A 5 ’側片斷之步驟, (1 )對於步驟k所得之片斷,將具有對該限制酶X 辨識切斷部位之序列呈互補性序列之X ’適應子予以加成 之步驟, (m )使用對該Y ’適應子序列具有互補性序列且其 3 ’終端具有任意二個鹼基序列N N之引子所構成之組合 ,與對該X ’適應子序列具有互補性序列且其3 ’終端具 有任意二個鹼基序列N N之引子所構成之組合,進行 P C R反應之步驟, (η )將步驟g和步驟m中所得之P C R產物進行電 泳,經由檢測移動距離和波峰,製作基因表現解析圖之步 驟。 1 〇 .如申請專利範圍第9項之製作基因表現解析圖 之方法,其中對步驟g中所使用之該X適應子序列具有互 補性序列且其3 ’終端具有任意二個鹼基序列N N之引子 ,係再於其5 ’終端加成螢光物質;及 對步驟m中所使用之該Y ’適應子序列具有互補性序 列且其3 ’終端具有任意二個鹼基序列N N之引子爲再於 其5 ’終端加成螢光物質; 藉此,該P C R產物之電泳結果爲經由檢測出該螢光 物質之螢光量而進行。 1 1 ·如申請專利範圍第9項之製作基因表現解析圖 (請先聞讀背面之注意事項再填寫本頁) £ 訂 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -49- 1237663 κ、申請專利範圍 ABCD 經濟部智慧財產局員工消費合作社印製 之 方 法 5 其 中 該 限 :制 酶 X 及該 限制酶 〖Υ爲由下歹〔 1所 ‘示 之 酵 素 群 中 分 別 選 出 ; A C C I I &gt; A f a I &gt; A 1 U I A S P L E I Λ B f a I 、Β S c F I &gt; B S h 1 2 3 6 I Λ B S hi Λ B s i S I 、 B S P 1 4 3 I Β S t U I Λ B s u R I 、 C f 〇 I C S P 6 I Dp η I I 、F n u D I I Λ Η a e I I I Η a P I I ^ Η ha I、H i n 2 I Η 1 n 6 I Η 1 η P 1 I &gt; Η P a I I &gt; Η s P 9 2 I I Η S P A I K z 〇 9 I 、M a e I Μ b 0 I 、 Μ s e I Μ s p I 、M v η I 、N d e I I 、 N 1 a I I I Λ Ρ a I I ^ R s a I 、S a u 3 A I S s e 9 I Λ T a Q I Λ T h a I ^ Trull τ r u 9 I 、 T s Ρ 5 0 9 1 Λ T s Ρ E I及 τ t h H B 8 I 0 1 2 • 如 甲 請 專 利 範 圍第 9 項之 製作基因表 現 解 析 圖 之 方 法 其 中 該 限 制 酶 X 爲M S pi ,且該限制酶’ F爲 Μ s e I 〇 1 3 • 如 串 三主 日円 專 利 範 圍第 9 項之 製作基因表 現 解 析 圖 之 方 法 5 其 中 該 X 適 應 子 中所 含 之N N和Y適應 子 中 所 含 之 N N 爲 將 腺 嘌 呤 Λ 胸 腺 嘧啶 Λ 鳥曝 呤及胞嘧啶 組 合 設 計 者 且 全 部 使 用 2 5 6 種 之X 及 Y適 應子。 1 4 . 如 串 請 專 利 範 圍第 9 項之 製作基因表 現 解 析 圖 之 方 法 其 中 該 標 的 物 質 與對 標 的物 質具有高親 和 性 之 物 質 之 組 合 係 選 白 由 生 物 素 和鏈 霉 抗生 物素蛋白、 生 物 素 和 (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 、1Τ, -50- 1237663 經濟部智慧財產局員工消費合作社印製 A8 B8 C8 D8 六、申請專利範圍 7 抗生物素蛋白、F ITC和F ITC抗體、D I G和抗 D I G、蛋白質a和鼠I g G、及膠乳粒子所組成群中。 1 5 ·如申請專利範圍第9項之製作基因表現解析圖 之方法,其爲於經由將該P C R產物予以電泳,檢測出移 動距離和波峰,製作基因表現解析圖之步驟後, 再具備將檢測出之波峰回收且以定序列決定出其所含 之P C R產物之序列,並且鑑定所表現基因之步驟。 1 6 ·如申請專利範圍第9項之製作基因表現解析圖 之方法,其爲再具備將該限制酶X及限制酶Y之辨識序列 、和步驟a所得之反應產物以限制酶X及限制酶Y切斷所 得之片斷長度、和任意數據庫所取得之數據,於電腦上進 行比較,鑑定出經表現基因之步驟。 1 7 · —種解析基因表現頻率之方法,具備下述步驟 (1 )對於對照細胞被檢細胞兩者,經由進行下列步 驟,以製作基因表現解析圖之步驟; (a )對於由細胞所抽提之m R N A,合成於其3 ’ 終端上加成標的物質之c D N A之步驟, (b )將所得之反應產物以第一限制酶X予以切斷之 步驟, (C )將具有對第一限制酶X之限制酶切斷部位之序 列呈互補性序列的X適應子,對於步驟b所得之片斷進行 結合之步驟, (d )經由對該標的物質結合具有高親和性之物質, 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁)-48- 1237663 A8 B8 C8 D8 Patent application scope 5 Printed by the Consumer Cooperative of Intellectual Property Bureau of the Ministry of Economic Affairs · (k) Cut the fragment recovered in step j with restriction enzyme X to remove the fragment bound to the target substance, Then, a step containing the 5 ′ side fragment of c DNA cleaved can be obtained. (1) For the fragment obtained in step k, an X ′ aptamer having a sequence complementary to the restriction enzyme X recognition cut site is added. (M) using a combination of primers that are complementary to the Y 'aptamer sequence and whose 3' terminal has any two base sequences NN, and complementary to the X 'aptamer sequence A sequence consisting of the primers of the sequence and its 3 ′ terminal having any two base sequences NN, and performing a PCR reaction step, (η) performing electrophoresis on the PCR products obtained in step g and step m, by detecting the moving distance and the peak Steps to make a gene expression analysis map. 10. The method for preparing a gene expression analysis map according to item 9 of the scope of patent application, wherein the X adaptor sequence used in step g has a complementary sequence and its 3 ′ terminal has any two base sequences NN The primer is a fluorescent substance added to its 5 'terminal; and the primer having a complementary sequence to the Y' adaptor sequence used in step m and its 3 'terminal having any two base sequences NN is the A fluorescent substance is added to its 5 'terminal; thereby, the electrophoresis result of the PCR product is performed by detecting the fluorescent amount of the fluorescent substance. 1 1 · If you make a gene expression analysis chart for item 9 of the scope of patent application (please read the notes on the back before filling this page) £ The size of the paper is applicable to the Chinese National Standard (CNS) A4 (210X297 mm)- 49- 1237663 κ, patent application scope ABCD Method printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs 5 Wherein the limit: enzyme X and the restriction enzyme 〖Υ are selected from the group of enzymes shown in the following [1] ; ACCII &gt; A fa I &gt; A 1 UIASPLEI Λ B fa I, Β S c FI &gt; BS h 1 2 3 6 I Λ BS hi Λ B si SI, BSP 1 4 3 I Β S t UI Λ B su RI, C f 〇ICSP 6 I Dp η II, F nu DII Λ Η ae III Η a PII ^ Η ha I, H in 2 I Η 1 n 6 I Η 1 η P 1 I &gt; Η P a II &gt; P s P 9 2 II Η SPAIK z 〇9 I, Mae I Μ b 0 I, Μ se I Μ sp I, M v η I, N de II, N 1 a III Λ P a II ^ R sa I, S au 3 AIS se 9 I Λ T a QI Λ T ha I ^ Trull τ ru 9 I, T s 5 0 9 1 Λ T s Pl EI and τ th HB 8 I 0 1 2 • The method of making a gene expression analysis chart according to item 9 of the patent, where the restriction enzyme X is MS pi and the restriction enzyme 'F Μ se I 〇1 3 • Method 5 for the analysis of gene expression, as described in item 9 of the three main sundial patents, where the NN contained in the X aptamer and the NN contained in the Y aptamer are glands The designers of the combination of purine Λ thymidine guanine and cytosine all use 2 5 6 kinds of X and Y aptamers. 14. If you ask for the method of making a gene expression analysis chart in item 9 of the patent scope, the combination of the target substance and the substance with high affinity to the target substance is selected from biotin and streptavidin, biological Suhe (Please read the notes on the back before filling this page) This paper size applies to Chinese National Standard (CNS) A4 specification (210 × 297 mm), 1T, -50-1237663 Printed by A8, Consumer Cooperative of Intellectual Property Bureau, Ministry of Economic Affairs B8 C8 D8 6. Scope of patent application 7 Avidin, F ITC and F ITC antibodies, DIG and anti-DIG, protein a and mouse I g G, and latex particles. 15 · According to the method of making a gene expression analysis chart in item 9 of the scope of patent application, after the PCR product is electrophoresed, the moving distance and wave peak are detected, and the step of making a gene expression analysis chart is provided, and then the detection method is provided. The recovered peaks are recovered and the sequence of the PCR products contained in the determined sequence is determined, and the steps of identifying the expressed genes are performed. 16 · According to the method for generating a gene expression analysis map in item 9 of the scope of the patent application, it further comprises the identification sequence of the restriction enzyme X and the restriction enzyme Y, and the reaction product obtained in step a to restrict the enzyme X and the restriction enzyme. The length of the fragment obtained by Y cutting and the data obtained from any database are compared on a computer to identify the expressed genes. 17 · A method for analyzing the frequency of gene expression, including the following steps (1) For both control cells and test cells, the following steps are performed to make a gene expression analysis map; (a) For the sample drawn by the cell The step of synthesizing the m RNA and synthesizing the c DNA of the target substance at its 3 ′ terminal, (b) the step of cutting the obtained reaction product with the first restriction enzyme X, (C) Restriction enzyme X The sequence of the restriction enzyme cutting site is a complementary sequence of the X aptamer, the step of combining the fragments obtained in step b, (d) by binding a substance with a high affinity to the target substance, this paper scale Applicable to China National Standard (CNS) A4 specification (210X297 mm) (Please read the precautions on the back before filling this page) -51 - 1237663 A8 B8 C8 D8 六、申請專利範圍 8 則可回收步驟c所得片斷之步驟, (e )將步驟d所回收之片斷以第二限制酶Y予以切 斷,除去結合至該標的物質之片斷,則可取得含有經切斷 c D N A 5 ’側片斷之步驟, (f )對於步驟e所得之片斷’將具有對第二限制酶 Y辨識切斷部位之序列呈互補性序列之γ適應子予以加成 之步驟’ (g )使用對該X適應子序列具有互補性序列且其 3,終端具有任意二個鹼基序列N N之引子,與對該Y適 應子序列具有互補性序列且其3 ’終端具有任意二個鹼基 序列NN之引子,並對於前述步驟f所得之片斷進行 P C R反應之步驟, (h )將所得之P C R產物進行電泳,經由檢測移動 距離和波峰,製作基因表現解析圖之步驟;及 (2 )經由比較該步驟(1 )所得之二個基因表現解 析圖,解析被檢細胞之基因表現頻率變化之步驟。 1 8 · —種解析基因表現頻率之方法,具備下述步驟 (1 )對於對照細胞和被檢細胞兩者,經由進行下列 步驟,製作基因表現解析圖之步驟; (a )對於由細胞所抽提之m R N A,合成其^終 端加成標的物質之c D N A,並將所得之合成產物分成二 個餾分之步驟, (b )將第一合成產物餾分以第一限制酶X予以切斷1 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) —訂 經濟部智慧財產局員工消費合作社印製 -52- 1237663 經濟部智慧財產局員工消費合作社印製 A8 B8 C8 D8 六、申請專利範圍 9 之步驟, (C )將具有對第一限制酶X之限制酶切斷部位之序 列呈互補性序列的X適應子,對於步驟b所得之片斷進行 結合之步驟, (d )經由對該標的物質結合具有高親和性之物質, 則可回收步驟c所得片斷之步驟, (e )將步驟d所回收之片斷以第二限制酶Y予以切 斷,除去結合至該標的物質之片斷,則可取得含有經切斷 c D N A 5 ’側片斷之步驟, (f )對於步驟e所得之片斷,將具有對第二限制酶 Y辨識切斷部位之序列呈互補性序列之Y適應子予以加成 之步驟, (g )使用對該X適應子序列具有互補性序列且其 3,終端具有任意二個鹼基序列N N之引子,與對該Y適 應子序列具有互補性序列且其3 ’終端具有任意二個鹼基 序列N N之引子,並對於前述步驟ί所得之片斷進行 P C R反應之步驟, (h )將步驟a所得之第二合成產物餾分以限制酶γ 予以切斷之步驟, (i )將具有對該限制酶Υ之限制酶切斷部位之序列 呈互補性序列的Y ’適應子,對於步驟h所得之片斷進行 結合之步驟, (j )經由對該標的物質結合具有高親和性之物質’ 則可回收步驟i所得片斷之步驟’ 本紙張尺度適用中國國家榇準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁)-51-1237663 A8 B8 C8 D8 6. The scope of patent application 8 can recover the fragment obtained in step c, (e) Cut the fragment recovered in step d with the second restriction enzyme Y to remove the substance bound to the target A fragment containing the c's DNA 5 'side fragment can be obtained. (F) For the fragment obtained in step e', it will have a γ adaptation that is complementary to the sequence of the second restriction enzyme Y recognition of the cut site. (G) Use a primer that has a complementary sequence to the X aptamer sequence and 3 of which has a terminal with any two base sequences NN, and a primer that has a complementary sequence to the Y aptamer sequence and its The 3 ′ terminal has primers of any two base sequences NN, and performs a PCR reaction on the fragment obtained in the foregoing step f. (H) The obtained PCR product is electrophoresed, and the gene expression analysis is made by detecting the moving distance and wave peak. Step of the graph; and (2) the step of analyzing the change of the gene expression frequency of the test cell by comparing the two gene expression analysis maps obtained in the step (1). 1 ·· A method for analyzing the frequency of gene expression, including the following steps (1) For both the control cell and the test cell, the following steps are performed to make a gene expression analysis map; (a) For the sample drawn by the cell Extract the m RNA to synthesize the c DNA of the ^ terminal addition target substance and divide the obtained synthetic product into two fractions. (B) Cut the first synthetic product fraction with the first restriction enzyme X. The paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) (Please read the notes on the back before filling this page) — Ordered by the Intellectual Property Bureau of the Ministry of Economic Affairs and printed by the Consumer Cooperatives -52- 1237663 Intellectual Property Bureau of the Ministry of Economic Affairs A8, B8, C8, D8 printed by the employee's consumer cooperative. 6. In step 9 of applying for a patent, (C) an X aptamer that has a complementary sequence to the restriction enzyme cutting site of the first restriction enzyme X. For step b, The step of combining the fragments, (d) By combining a substance with a high affinity for the target substance, the step of the fragment obtained in step c can be recovered, and (e) the step d is recovered. The fragment is cut with the second restriction enzyme Y, and the fragment bound to the target substance is removed, and a step containing the c '5' side fragment of cleaved DNA can be obtained. (F) For the fragment obtained in step e, the The step of adding the Y adaptor whose complementary sequence of the two restriction enzyme Y recognition cut-off site is complementary, (g) using a complementary sequence to the X adaptor sequence and 3, the terminal having any two base sequences A primer of NN and a primer of complementarity to the Y adaptor sequence and a primer of any two base sequence NN at its 3 ′ terminal, and a step of performing a PCR reaction on the fragment obtained in the foregoing step (h) The second synthetic product fraction obtained by a step of cleaving with restriction enzyme γ, (i) a Y ′ aptamer having a complementary sequence to the restriction enzyme cleaving site of the restriction enzyme Υ, for step h The step of combining the fragments, (j) The step of recovering the fragment obtained in step i by combining the substance with high affinity to the target substance 'This paper standard applies to China National Standards (CNS) A4 Grid (210X297 mm) (Please read the back of the precautions to fill out this page) -53- 1237663 A8 B8 C8 D8 六、申請專利範圍 1〇 (k )將步驟j所回收之片斷以限制酶X予以切斷, 除去結合至該標的物質之片斷,則可取得含有經切斷 c D N A 5 ’側片斷之步驟, (1 )對於步驟k所得之片斷’將具有對該限制酶X 辨識切斷部位之序列呈互補性序列之X ’適應子予以加成 之步驟, (m )使用對該Y ’適應子序列具有互補性序列且其 3 ’終端具有任意二個鹼基序列N N之引子所成組合’與 對該X ’適應子序列具有互補性序列且其3 ’終端具有任 意二個鹼基序列N N之引子所成組合,以進行P C R反應 之步驟, (η )將步驟g與步驟m中所得之P C R產物進行電 泳,經由檢測移動距離和波峰,製作基因表現解析圖之步 驟;及 (2 )經由比較該步驟1所得之二個基因表現解析圖 ,解析被檢細胞之基因表現頻率變化之步驟。 (請先閲讀背面之注意事項再填寫本頁) .裝· 訂 經濟部智慧財產局員工消費合作社印製 本紙張尺度適用中國國家標準(CNS ) A4規格(21〇X:297公釐)-53- 1237663 A8 B8 C8 D8 VI. Patent application scope 10 (k) Cut the fragment recovered in step j with restriction enzyme X, and remove the fragment bound to the target substance, then you can get the c Step of DNA 5 'side fragment, (1) For the fragment obtained in step k', a step of adding an X 'aptamer having a complementary sequence to the sequence of the restriction enzyme X recognition cut site, (m) using A combination of primers having complements to the Y 'adaptor sequence and 3' terminal having any two base sequences NN 'and having complements to the X' adaptor sequence and 3 'terminal having any two A combination of primers of a base sequence NN to perform a PCR reaction, (η) a step of electrophoresis of the PCR product obtained in step g and step m, and a step of generating an analysis map of gene expression by detecting a moving distance and a peak; And (2) the step of analyzing the change in the gene expression frequency of the test cell by comparing the two gene expression analysis maps obtained in step 1. (Please read the precautions on the back before filling out this page). Binding and printing Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs This paper applies the Chinese National Standard (CNS) A4 specification (21 ×: 297 mm)
TW090130806A 2000-12-12 2001-12-12 Method of analyzing expression of gene TWI237663B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000377887 2000-12-12

Publications (1)

Publication Number Publication Date
TWI237663B true TWI237663B (en) 2005-08-11

Family

ID=18846547

Family Applications (1)

Application Number Title Priority Date Filing Date
TW090130806A TWI237663B (en) 2000-12-12 2001-12-12 Method of analyzing expression of gene

Country Status (8)

Country Link
US (2) US20040005625A1 (en)
EP (1) EP1348762B1 (en)
JP (1) JP4437171B2 (en)
AU (2) AU2261802A (en)
CA (1) CA2431170C (en)
DE (1) DE60141221D1 (en)
TW (1) TWI237663B (en)
WO (1) WO2002048352A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7498135B2 (en) 2003-06-19 2009-03-03 National Institute Of Radiological Sciences Method for preparing gene expression profile
JP4217780B2 (en) * 2003-06-19 2009-02-04 独立行政法人放射線医学総合研究所 Gene expression profile creation method
US7192824B2 (en) * 2003-06-24 2007-03-20 Micron Technology, Inc. Lanthanide oxide / hafnium oxide dielectric layers
JP5253703B2 (en) * 2004-03-12 2013-07-31 アイシン精機株式会社 Gene fragment acquisition method
CA2569486A1 (en) * 2004-06-03 2005-12-15 National Institute Of Radiological Sciences For the analysis of exclusive gene expression profile using a trace amount of sample
US7542854B2 (en) 2004-07-22 2009-06-02 International Business Machines Corporation Method for discovering gene regulatory models and genetic networks using relational fuzzy models
JPWO2006038416A1 (en) * 2004-10-06 2008-05-15 独立行政法人放射線医学総合研究所 Comprehensive analysis of transcriptional active regions (unmethylated regions) on the genome
WO2008111453A1 (en) * 2007-03-07 2008-09-18 The University Of Tokyo Method for amplification of dna fragment
JP5213009B2 (en) * 2007-03-15 2013-06-19 独立行政法人放射線医学総合研究所 Gene expression variation analysis method and system, and program
JP5344670B2 (en) * 2008-02-13 2013-11-20 独立行政法人放射線医学総合研究所 Gene expression analysis method, gene expression analysis apparatus, and gene expression analysis program
US10593886B2 (en) * 2013-08-25 2020-03-17 Molecular Glasses, Inc. OLED devices with improved lifetime using non-crystallizable molecular glass mixture hosts

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700637A (en) * 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US5744101A (en) * 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5262311A (en) * 1992-03-11 1993-11-16 Dana-Farber Cancer Institute, Inc. Methods to clone polyA mRNA
DE69332665T2 (en) * 1992-03-11 2003-11-27 Dana Farber Cancer Inst Inc METHOD TO CLONE MRNA
US5876978A (en) * 1993-04-06 1999-03-02 Medical College Of Ohio Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction
US5807522A (en) * 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
EP0735144B1 (en) * 1995-03-28 2002-06-05 Japan Science and Technology Corporation Method for molecular indexing of genes using restriction enzymes
US5871697A (en) * 1995-10-24 1999-02-16 Curagen Corporation Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing
CA2188713A1 (en) * 1995-10-27 1997-04-28 Robert Collu Internal standards for quantitative competitive pcr
US5948615A (en) * 1996-04-16 1999-09-07 Hitachi, Ltd. Method for analysis of nucleic acid and DNA primer sets for use therein
US5981733A (en) * 1996-09-16 1999-11-09 Incyte Pharmaceuticals, Inc. Apparatus for the chemical synthesis of molecular arrays
WO1998035058A2 (en) * 1997-02-07 1998-08-13 Ribozyme Pharmaceuticals, Inc. Improved process for detection and quantification of nucleic acid molecules
EP0981609B1 (en) * 1997-05-13 2001-09-19 Azign Bioscience A/S A method to clone mrnas and display of differentially expressed transcripts (dodet)
JP3784162B2 (en) * 1998-01-14 2006-06-07 株式会社日立製作所 DNA fragment analysis
GB9817055D0 (en) * 1998-08-05 1998-09-30 Medical Res Council Reverse transcription and amplification processes and primers therefore
JP3414679B2 (en) * 1999-05-25 2003-06-09 菊也 加藤 RNA detection method
US6248534B1 (en) * 1999-05-25 2001-06-19 Kikuya Kato Method for determining the detection value of a target RNA
US6221600B1 (en) * 1999-10-08 2001-04-24 Board Of Regents, The University Of Texas System Combinatorial oligonucleotide PCR: a method for rapid, global expression analysis
JP2001299394A (en) * 2000-04-26 2001-10-30 Unitech Kk Comparative detection of amounts of rna
US7498135B2 (en) * 2003-06-19 2009-03-03 National Institute Of Radiological Sciences Method for preparing gene expression profile

Also Published As

Publication number Publication date
CA2431170A1 (en) 2002-06-20
EP1348762B1 (en) 2010-01-27
EP1348762A4 (en) 2005-08-10
DE60141221D1 (en) 2010-03-18
AU2261802A (en) 2002-06-24
US20090325185A1 (en) 2009-12-31
CA2431170C (en) 2011-07-26
AU2002222618B2 (en) 2005-06-30
WO2002048352A1 (en) 2002-06-20
JPWO2002048352A1 (en) 2004-11-04
JP4437171B2 (en) 2010-03-24
US20040005625A1 (en) 2004-01-08
EP1348762A1 (en) 2003-10-01

Similar Documents

Publication Publication Date Title
Zhang et al. Comparative analysis of droplet-based ultra-high-throughput single-cell RNA-seq systems
JP6977014B2 (en) Transfer to Natural Chromatin for Individual Epigenomics
JP5846703B2 (en) Polynucleotide mapping and sequencing
US20220246234A1 (en) Using cell-free dna fragment size to detect tumor-associated variant
Philpott et al. Nanopore sequencing of single-cell transcriptomes with scCOLOR-seq
Baslan et al. Genome-wide copy number analysis of single cells
KR20180123020A (en) Use of DNA fragment size to determine copy number variation
CN108300767B (en) Analysis method for interaction of nucleic acid segments in nucleic acid complex
TWI237663B (en) Method of analyzing expression of gene
Zanders et al. Analysis of immune system gene expression in small rheumatoid arthritis biopsies using a combination of subtractive hybridization and high-density cDNA arrays
JP2022160425A (en) Method for collective quantification of target proteins using next-generation sequencing and uses thereof
KR20180041331A (en) The method and kit of the selection of Molecule-Binding Nucleic Acids and the identification of the targets, and their use
CN114875118B (en) Methods, kits and devices for determining cell lineage
US20220002797A1 (en) Full-length rna sequencing
CN112703253A (en) Use of droplet single cell epigenomic profiling for patient stratification
US20240117423A1 (en) Quantitative detection and analysis of molecules
WO2024006712A1 (en) Methods for preparation and analysis of proximity-ligated nucleic acids from single cells
WO2022192189A1 (en) Methods and compositions for analyzing nucleic acid
WO2022164893A1 (en) Quantification of cellular proteins using barcoded binding moieties
US20130023427A1 (en) Methods for assessing genomic instabilities in tumors
Powell 26 The Detection of Differential Gene Expression Changes Using SAGE (Serial Analysis of Gene Expression)
Russo et al. RNA Sequencing in the Human Breast

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees